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Chapter 1:  Introduction and Literature Review 
  
1.1  Thesis Introduction 
 Performing surgery on cattle is a significant part of a large animal veterinarian’s duties.  
A large number of these surgical procedures involve entering the animal’s abdominal cavity, 
whether for a Caesarian section, fixing a displaced abomasum, performing an exploratory 
laparotomy, or repairing an umbilical hernia.   Many of these surgical procedures are performed 
on farm rather than in a veterinary clinic.  Unfortunately, this entails operating in conditions that 
are less than optimal, as a hygienic surgical environment may not be possible.  Unhygienic 
conditions may result in post-surgical infections that threaten the production and well-being of 
the animal.  In an effort to prevent the deleterious effects of a post-surgical infection, many 
veterinarians administer perioperative antimicrobials, sometimes directly into the abdominal 
cavity.  This intraperitoneal (IP) use of antimicrobials has not been well studied in animals in 
general and cattle in particular.  Pharmacokinetic differences between IP and other routes of 
administration are not known for most antimicrobials in cattle.  As well, meat and milk drug 
residues kinetics are unknown after IP administration.   Whether IP antimicrobials inflame or 
irritate the abdominal cavity and peritoneum is unknown.  Finally, no evidence exists to verify 
that IP antimicrobial use prevents postoperative infections in cattle.  Although the author utilized 
IP antimicrobials routinely while performing bovine surgery, no information was available to 
support or refute this practice.  These unanswered questions raise a larger issue: is IP 
antimicrobial use during bovine surgery justifiable?  This thesis examines part of this broad 
subject by describing the plasma kinetics, milk and meat residues, and safety profile after IP 
administration of procaine penicillin G in lactating dairy cows. 
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1.2  Extra-label Drug Use (ELDU) 
 Using any medication in a manner different from the specific label directions constitutes 
extra-label drug use (ELDU).  This includes altering the dosage, route, or duration of therapy; or 
using the product on a species or for a condition not specified on the drug label.  Antimicrobials 
currently approved for use in cattle have label instructions for various routes of administration, 
including intramuscular (IM), subcutaneous (SC), intravenous (IV), oral, topical, or some 
combination of these routes.  However, no product is labeled for IP use.  Therefore 
administration of antimicrobials by the IP route in cattle constitutes ELDU, and evaluating IP use 
in cattle requires an understanding of the issues surrounding ELDU.   
1.2.1  ELDU Legislation and Guidelines 
 Because of the limited number of veterinary pharmaceuticals and label indications 
available, ELDU is essential to the modern practice of veterinary medicine.  Under the federal 
Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994, the United States recognizes 
a veterinarian’s ability to perform ELDU, providing certain criteria are met (CVM, 2002).  
Canada’s Veterinary Drug Directorate (VDD) concurs, stating that ELDU is not in violation of 
the Food and Drugs Act and Regulations (VDD, 2005).  However, the necessary conditions 
required prior to ELDU are not explicitly stated, except that ELDU must not result in violative 
drug residues.  The Canadian Veterinary Medical Association (CVMA) and other provincial and 
species-specific veterinary associations support ELDU guidelines similar to those presented in 
AMDUCA, though not codified as explicitly (CVMA, 2002).    
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1.2.2  Animal Medicinal Drug Use Clarification Act  
 The passage of AMDUCA formally recognizes the practice of ELDU, but only if certain 
conditions are met (CVM, 2002).  The first provision states that acceptable ELDU requires using 
an approved animal or human drug.  It must only be performed on the order of a licensed 
veterinarian within the context of a veterinary-client-patient relationship (VCPR).  Another 
important, yet often overlooked, condition is that ELDU is limited to cases when the health of 
the animal is threatened or suffering or death may result from failure to treat.  Growth promotion 
and reproductive therapy are not acceptable reasons for ELDU.  Regarding ELDU in food-
producing animals, further conditions must also be met, including: 
• There is no approved animal drug that is labeled for this particular use that is likely to be 
clinically effective. 
 
• The veterinarian has made a careful diagnosis and evaluation of the conditions for which 
this ELDU will occur. 
 
• A substantially extended withdrawal period has been established prior to marketing food 
products from animals treated by ELDU, and no illegal drug residues will occur. 
 
1.2.3  CVMA Extra-label Drug Use Guidelines 
 Although ELDU in Canada is not codified in federal law as in the United States, the 
CVMA position statement on extra-label drug use in animals contains similar themes to 
AMDUCA (CVMA, 2002).  It encourages Canadian veterinarians to use and prescribe approved 
veterinary drugs as per the label instructions.  However, it recognizes that ELDU is justified “if 
the prescribing veterinarian has scientific evidence that it is in the best interests of the animal”, 
and does not contravene any provincial regulation.  Although few, if any, provincial veterinary 
acts specifically regulate ELDU in animals, determining the appropriateness of ELDU in specific 
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situations will inevitably fall on the leadership of each provincial veterinary medical association.  
The CVMA guidelines also reiterate that only veterinarians, in a valid VCPR, are qualified to 
order ELDU in animals.  As well, veterinarians must “educate themselves and their clients on 
appropriate withdrawal times and the liabilities associated with non-approved use”.    
1.2.4  WCABP Extra-label Drug Use Guidelines 
 The Western Canadian Association of Bovine Practitioners (WCABP) has published their 
own position statement on ELDU for bovine practitioners (WCABP, 2005).  Like the CVMA 
position statement, it does not spell out specific provisions for acceptable ELDU.  Rather, it 
reiterates the necessity of ELDU in bovine practice, the importance of veterinary supervision and 
a VCPR, and the veterinarian’s liability if violative residues occur after ELDU. 
1.2.5  IP Drug Use in Relation to ELDU 
 As stated earlier, because no antimicrobial is labeled for IP use this practice is by 
definition ELDU.  But does IP administration meet the aforementioned criteria for acceptable 
ELDU?  Because the Canadian guidelines are non-specific (only stating “Scientific evidence that 
ELDU is in the best interest of the animal”), this practice is easier to evaluate using the 
definitions outlined in AMDUCA.  Since IP antimicrobial use is only likely to occur during 
bovine abdominal surgery, which should only be performed by a licensed veterinarian, the 
criteria for a veterinary order and valid VCPR are met.  As well, since there are no animal drug 
products specifically labeled for either IP use or surgical prophylaxis, the directive to use an 
“approved product on-label” first has also been met.  However, if one strictly applies the criteria 
for proper ELDU, IP antimicrobial use may not be acceptable.  It is debatable if IP antimicrobial 
“prophylaxis” constitutes justifiable ELDU, as the health of the animal may not be threatened if 
IP treatment is withheld.  If the veterinarian suspects surgical contamination and possibly 
4 
 
infection, other antimicrobials are labeled for the treatment of this condition.  For example, IM or 
IV injections of short-acting oxytetracycline are labeled for the treatment of peritonitis, and IM 
injections of procaine penicillin G are labeled for the treatment of wound infections.  One could 
argue that either drug may be clinically ineffective for these conditions if given by IM injection 
postoperatively, or that intraoperative IP antimicrobial use is theoretically more effective (though 
no data currently exists to prove this).  The other reason IP antimicrobial use contravenes ELDU 
guidelines is that no scientific evidence is available on which to base meat or milk withdrawal 
intervals.  Therefore, even if withdrawal intervals longer than the label IM withdrawal times are 
recommended by the veterinarian, there is no guarantee that violative residues will not occur.   
1.3  Drug Residues in Food Animals and Drug Residue Testing 
 Before discussing the kinetics of antimicrobial residues in meat and milk after IP 
administration in cattle, a general understanding of issues surrounding drug residues in food is 
required.  Animal agriculture promotes its food products as safe and nutritious for the consumer.  
An important component of this “wholesome” message is the underlying assumption that nothing 
“unwholesome” is present.  Food products contaminated with drug residues (including 
antimicrobials) are considered a public health hazard by both regulatory agencies and the public 
at large.  Adverse reactions (hypersensitivity), continued emergence of antimicrobial resistance, 
and carcinogenicity or teratogenicity have been linked to antimicrobial residues in food.  As a 
result, producers have proactively adopted prudent use guidelines in an effort to minimize 
violative drug residues.  As well, regulatory agencies actively screen for drug residues in food of 
animal origin.  In conjunction with these groups, veterinarians play an important role ensuring 
residues of medications used on farm do not reach the consumer.   
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1.3.1  Negative consequences of antimicrobial residues in food of animal origin 
Risk to human health: Adverse drug reactions, such as hypersensitivity or allergic reactions, are 
possible if susceptible individuals consume contaminated meat or milk products.  Approximately 
5-10 percent of people are hypersensitive to penicillin (Dayan, 1993).  Allergic reactions 
including skin rashes, hives, asthma, and possibly anaphylactic shock are possible if susceptible 
individuals ingest small quantities of penicillin (Wicher et al., 1969; Lindemayr et al., 1981; 
Kanny et al., 1994)   Although there is potential for adverse reactions after penicillin residue 
ingestion, the number of confirmed cases is very small (Sundlof, 1989; Dewdney et al., 1991; 
Dayan, 1993)  Emergence of antimicrobial resistance in human enteric bacteria caused by 
exposure to antimicrobial residues in food of animal origin is another concern (Tollefson, 2006).  
Antimicrobials present in food are thought to put selective pressure on antimicrobial-susceptible 
enteric bacteria, thus favouring resistant strains.  Finally, some antimicrobials are banned for use 
in food producing animals due to the potentially catastrophic effects of drug residues.  For 
example, chloramphenicol causes irreversible aplastic anemia in a small proportion of 
individuals.  Other antimicrobials banned for use in food animals, such as metronidazole and 
nitrofurazone, are carcinogenic or teratogenic in laboratory species (Dowling, 2006).  
Public perception: While the true risk to humans of antimicrobial residues in food is debatable, 
the public considers any drug residue in food as unhealthy or unsafe.  Publicity of drug residues 
in meat or milk products results in decreased consumer confidence and threatens international 
trade.  Animal agriculture and government agencies therefore have a vested interest to ensure 
food products containing drug residues do not reach either domestic or international markets.  
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Manufacturing/food processing: Antimicrobials in milk cause difficulty for the milk processor 
who purchases milk from the farmer.  Antimicrobials hinder the production of dairy products and 
may result in reduced quality butter, yogurt, and cheese (Jones, 1999; Molina et al., 2003; Payne 
et al., 2006)  
1.3.2  Common Drug Residue Violations in Cattle 
 Regulation of milk and dairy drug residue testing in Canada is done on a provincial basis, 
and results of residue testing are not readily available.  Actual testing protocols, such as 
frequency and types of antimicrobial testing, vary with jurisdiction and individual processors.  A 
limited residue surveillance program is conducted by the Canadian Food Inspection Agency 
(CFIA).  However, this program only analyzes products already marketed for sale after 
provincial and/or processor testing and does not account for any residue violations found prior to 
marketing.  Therefore, the results of federal testing do not reflect the true incidence of 
antimicrobial residues in milk and dairy products.  In comparison, mandatory test reporting is 
required by American state regulatory agencies under the National Conference on Interstate Milk 
Shipments (NCIMS). Residue violations resulted in the discard of 76 million pounds of milk in 
2002/2003. The most common drug residue violations in milk in both Canada and the United 
States are for ß-lactam residues, including penicillin, ampicillin, amoxicillin, cloxacillin, 
cephapirin, and ceftiofur (NCIMS, 2003).  See Chapter 2 for more information on drug residue 
testing in milk. 
 Residue detection in beef falls under federal jurisdiction in both Canada (CFIA) and the 
United States (Food Safety Inspection Service, FSIS, a division of the United States Department 
of Agriculture).  Suspect carcasses are tested using rapid test kits (such as the Swab Test on 
Premises, STOP) in the slaughter plant.  General surveillance of beef distributed for sale also 
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occurs.  For example, in 2003/2004 in Canada, 811 beef samples were tested for drug residues 
with 98.1% cleared for sale (CFIA, 2006).  If specific antimicrobial residues are suspected in 
certain groups of animals, targeted surveillance is used.  Veal calves are notorious for 
aminoglycoside residues (especially neomycin), and are tested more frequently for these drugs 
(Gibbons et al., 1996; JAVMA, 2004).  
1.3.3  Reasons for Drug Residue Violations in Meat and Milk 
 Drug residues in milk are most often caused by improper use of antimicrobials for the 
control of mastitis.  The odds that a violative antimicrobial residue will be found in bulk tank 
milk increases with increasing somatic cell count (SCC) status of the herd (Sargeant et al., 1998; 
Ruegg & Tabone, 2000; Saville et al., 2000)  As the SCC is an indicator of the prevalence of 
mastitis within a herd, high SCC herds generally have more cows with mastitis requiring 
antimicrobial therapy, thus increasing the chance of milk residue violations.  Mastitic cows are 
routinely treated with antimicrobials in order to lower the SCC to acceptable levels.  Another 
predictor of increasing milk residue violations is large farm size, possibly due to 
miscommunication between multiple farm workers (van Schaik et al., 2002).  Specific reasons 
for antimicrobial residue violations in milk (such as insufficient communication between barn 
staff, incomplete treatment records, and poor cow identification) can all result in failure to 
observe the label withdrawal time (Kaneene & Ahl, 1987).  Drug residues in meat are caused by 
similar factors, again resulting in failure to observe the withdrawal time after drug administration 
(Paige et al., 1999). 
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1.3.4  Meat and milk withdrawal time determination 
 Before approving a new food animal drug, regulatory authorities establish an acceptable 
daily intake (ADI). The ADI represents a quantity of drug a person can ingest daily over a 
lifetime without appreciable risk to their health.  ADIs are determined from the No Observed 
Effect Level (NOEL), which is the highest quantity of drug tested on laboratory animals that 
showed no adverse effects (including morphology, carcinogenicity, reproductive safety, lifespan, 
etc.).  The ADI is calculated by dividing the NOEL by a safety factor, usually between 100 and 
1000 (Baynes et al., 1999).  The total ADI is allotted to meat and milk using different food 
consumption factors, to give each type of food a maximum allowable drug concentration.  Foods 
consumed in small amounts or infrequently are allowed greater drug concentrations than those 
foods consumed often or in large quantities (such as milk).  This maximum quantity of drug is 
known in Canada and the European Union as the maximum residue limit” (MRL).  The MRL is 
calculated such that daily intake of food containing drug residues at the MRL will result in a total 
daily consumption of residues in quantities at or below the ADI.  ADIs are based on the total 
residue of a chemical present in food (parent compound and all metabolites), whereas MRLs are 
based on a single, measurable marker residue (which may be the parent compound or any of its 
metabolites).    
 Once the MRL for a particular tissue or milk has been established, a withdrawal time 
(WDT) can be determined.  The label WDT for a drug is the amount of time required after 
treatment for tissue or milk residues to fall below the MRL in 99% of animals, with 95% 
confidence.  WDTs can only be determined by performing tissue or milk residue depletion 
studies.  This requires taking tissue or milk samples at numerous time points after drug 
administration and constructing a residue depletion curve.  Note the difference between the label 
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WDT as determined by regulatory agencies and a withdrawal interval (WDI) recommended by a 
veterinarian after ELDU, which should be longer than the WDT.  Because WDTs are based on 
the 99th percentile of animals with 95% probability, residue depletion studies with small sample 
sizes or large variability are likely to result in longer withdrawal times.  An extended meat WDT 
is not a major financial penalty for beef producers, as keeping cattle alive for a few extra days 
before slaughter is not terribly inconvenient.  However, prolonged milk withdrawal times are a 
major economic hardship for dairy farmers.  Assuming average milk production of 30 L/cow/day 
and a milk payment of $0.50 per litre, each day of milk discard costs the producer $15 in lost 
revenue. Therefore, dairy producers may not comply with excessively conservative WDI 
recommendations. 
1.3.5  The role of the CgFARAD 
 Because veterinarians must routinely engage in ELDU, they are obligated to determine 
appropriate meat and milk WDI for the producer.  Many veterinarians do not have appropriate 
pharmacokinetic training or cannot access the necessary scientific literature to make valid 
withdrawal estimations.  It is for these reasons that the US Food Animal Residue Avoidance 
Databank (FARAD), and its Canadian global offshoot (CgFARAD) were created.  Maintaining a 
comprehensive database containing pharmacokinetic data from scientific literature, proprietary 
drug trials, and international regulatory agencies allows staff pharmacologists to make 
scientifically-based withdrawal estimates for individual cases.  A central database can also 
recognize when gaps exist in the literature.  For example, the CgFARAD has received WDI 
requests after IP use of penicillin in cattle.  After examining the database and performing a 
literature search, little scientific information was available to support any WDI recommendation.  
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The lack of kinetic information after IP antimicrobial administration in cattle was the major 
reason for conducting the experiments in this thesis.    
1.3.6  Drug residue testing in milk and meat 
Milk testing: As stated earlier, testing for antimicrobial residues in milk is performed mainly by 
the processing plant to which the milk is delivered.  In Saskatchewan, before milk producers may 
ship milk to the processing plant they agree that no detectable drug residues will be present in 
their milk.  Numerous tests are available to screen for antimicrobial residues however, and each 
test has different sensitivities for individual compounds.  Therefore, results of a test used on-farm 
may not agree with results from a different test at the processing plant.  Most rapid, on-farm 
screening tests are microbial growth inhibition assays, although ELISA-based tests are also 
available.  Rapid screening test results are generally assessed visually and therefore give a 
qualitative “yes or no” answer.  Processing plants may employ more expensive and bulky semi-
quantitative equipment systems that rely on immuno- or microbial receptor assays.  Screening 
tests are validated only for use with bulk tank or tanker-truck milk samples.  No kits are currently 
validated for testing milk from individual cows.  Although milk screening tests can be extremely 
sensitive, they are not quantitative and cannot confirm a specific drug residue.  They are 
therefore designated Codex Level III methods, suitable for screening large numbers of samples 
quickly.  If federal regulatory agencies conducted milk testing, positive samples on a preliminary 
screening test would be subjected to further testing methods, which quantify (Codex Level I or II 
methods) and uniquely identify (Codex Level I only) the drug present.  Due to the short shelf-life 
of dairy products, this level of testing is not feasible as products would expire before conclusive 
results are available.  Because rapid milk screening tests are not quantitative, they cannot be used 
to establish a withdrawal time after drug administration.   
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 Meat:  Pre-slaughter testing for meat antimicrobial residues is more difficult than milk testing, as 
historically only post-slaughter tests were available.  Without a pre-slaughter test, a producer 
cannot ascertain when a treated animal will no longer contain violative meat residues.  The 
recently introduced MeatsafeTM ß-lactam test kit, a rapid immunoassay test, uses urine drug 
concentration to predict kidney residue concentrations and can be used for antemortem testing.   
1.3.7  IP antimicrobial use and drug residues 
 The IP administration of antimicrobials in cattle cannot be justified if the ensuing drug 
residue kinetics are not known.  An understanding of how a residue depletion experiment is 
properly conducted is required before attempting to determine these kinetics.  For example, 
appropriate study design of an IP antimicrobial residue depletion experiment requires knowledge 
of factors involved in WDT determination, such as sample size, timing, and variability.  The 
MRL of each antimicrobial in specific matrices, as well as the sensitivity of commonly used 
rapid test kits, is required for a reasonable WDT estimation.  An appropriate understanding of 
rapid screening test uses and limitations is necessary before they can be used effectively to 
screen for drug residues after IP administration.  Further information regarding milk residue 
testing is contained in Chapter 2 of this thesis. 
1.4  Antimicrobial Efficacy and Perioperative Use 
 The broader issue of IP antimicrobial use appropriateness necessitates an understanding 
of proper antimicrobial use in general.  The following is a brief summary of current antimicrobial 
uses in bovine medicine, predictors of antimicrobial efficacy, negative consequences of 
antimicrobial use in cattle, and information specific to perioperative use. 
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1.4.1  Antimicrobials licensed for use in cattle 
 Many older antimicrobials (such as penicillin and tetracyclines) are available to beef and 
dairy producers as over the counter drugs, which do not require a veterinary prescription. These 
products often contain multiple broad label indications based on regulatory approval granted 
long ago.  Newer antimicrobials (such as ceftiofur, florfenicol, tilmicosin, and tulathromycin) are 
subject to more rigorous regulatory analysis before approval; their label claims can be limited to 
specific pathogens that cause a particular disease (such as bovine respiratory disease caused by 
Mannheimia hemolytica).  Table 1 specifies the common injectable antimicrobials currently 
licensed in Canada for use in beef or dairy cattle, their indications, and routes of administration.  
Note extra-label administration of other products not licensed for use in cattle occurs. 
1.4.2  Antimicrobial pharmacokinetics and pharmacodynamics  
 Predicting success or failure when treating an infectious process requires an 
understanding of numerous host/bacteria/drug factors, collectively known as pharmacokinetics 
and pharmacodynamics (PK/PD).   
Pharmacokinetics (PK):  The processes of drug absorption, distribution, metabolism, and 
elimination (ADME) determine a drug’s PK profile.  These depend on the physical and chemical 
characteristics of the drug as well as host physiology and pathology.  Primary PK parameters 
depend only on the physiological process of ADME and include systemic clearance (ClS), 
volume of distribution (VD), and bioavailability (F).  Secondary PK parameters are derived from 
primary parameters and include maximal plasma drug concentration (Cmax), time to maximal 
concentration (Tmax), elimination half-life (T1/2 elim), and area under the plasma concentration 
versus time curve (AUC).   
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Pharmacodynamics (PD):  This is the pharmacological effect of the drug in the body; 
antimicrobial PD measures a drug’s efficacy in killing or inhibiting a particular bacterial species.  
Antimicrobial PD parameters include the minimum inhibitory concentration (MIC), which is the 
lowest concentration of drug required to inhibit in vitro antimicrobial growth on an agar culture 
or microtitre plate.  Note that only certain methods of antimicrobial susceptibility testing (such as 
multiple broth or agar dilutions or the Etest®, but not the Kirby-Bauer disc diffusion method) 
can be used to determine MIC values.  In some cases generalizations can be made about the 
efficacy of certain antimicrobials against a particular bacterial species (such as the resistance of 
E. coli to penicillin). However, the heterogeneity of bacterial resistance genes and their 
expression within a bacterial population means that a range of MICs will occur for an 
antimicrobial when tested on large number of a bacterial isolates from a particular species.   
PK/PD integration:  Once the host-drug PK and drug-pathogen PD are known, the PK/PD 
parameters can be integrated and modeled to make predictions of antimicrobial efficacy.  For 
example, if the plasma drug concentrations over a defined dosage interval are established (PK), 
but drug concentrations never reach the lowest quantity required to inhibit microbial growth 
during in vitro susceptibility testing (MIC, PD), it is unlikely that this antimicrobial dose will be 
efficacious in treating an infection with this bacterial isolate.  Current PK-PD models do not 
perfectly predict antimicrobial efficacy, however.  Because most infections are located in the 
extracellular or interstitial fluid, plasma drug concentrations form the basis of antimicrobial PK 
and are good surrogate markers of infection site drug concentrations and clinical efficacy 
(Gunderson et al., 2001).   Plasma drug concentrations are not representative of drug 
concentrations at the site of all infectious diseases, however.  For example, macrolides such as 
tilmicosin and tulathromycin have low plasma concentrations but very high lung and intracellular 
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concentrations, and are thus excellent choices for treating bovine pneumonia despite poor plasma 
PK/PD analyses (USP, 2003).  On the other hand, drugs with a low VD may not penetrate 
fibrinous pneumonic lung tissue and may be ineffective for treating lower respiratory tract 
infections despite achieving high plasma concentrations.   
Antimicrobial PK/PD:  Antimicrobials are generally classified into two PK-PD categories: time-
dependent and concentration-dependent.  Time-dependent antimicrobials are most efficacious 
when the length of time the drug concentration at the site of infection is maintained above the 
pathogen’s MIC is maximized (the PK/PD parameter T > MIC).  For classic time-dependent 
antimicrobials such as penicillins and cephalosporins, maximum clinical efficacy occurs when T 
> MIC is 50-80% of the dosing interval, although other recommendations range from 40-100% 
(Gunderson, Ross et al., 2001; McKellar et al., 2004; Toutain & Lees, 2004). Maximizing the 
drug concentration for a short period is not as efficacious as maintaining lower concentrations 
(but still above the MIC) for longer periods.  Therefore, efficacy of time-dependent 
antimicrobials is generally improved by increasing the dosing frequency, rather than increasing 
the dose.   Concentration-dependent antimicrobials are more efficacious when the drug 
concentration at the site of infection is maximized, even if for shorter periods of time.  The ratios 
Cmax:MIC and AUC:MIC are used as PK/PD parameters for concentration-dependent drugs.  
Ratios of Cmax:MIC of ≥ 8-10 and AUC:MIC of ≥ 100-125 have been recommended for 
fluororoquinolones and aminoglycosides (McKellar, Sanchez Bruni et al., 2004).  For 
concentration-dependent antimicrobials, increasing the dose is typically more effective than 
increasing the dosing frequency. 
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1.4.3  Adverse effects of antimicrobial use in cattle 
 
Direct adverse effects: Antimicrobial use can cause a wide range of adverse reactions or toxic 
effects in animals.  Although relatively rare in cattle, cutaneous hypersensitivity reactions have 
been reported after using ceftiofur and streptomycin (Gauchia et al., 1996; Tyler et al., 1998); 
potentiated sulfonamides and tetracyclines can cause anaphylaxis, especially after IV 
administration (CVP, 2005).  Renal damage can occur with repeated aminoglycoside or 
tetracycline doses, or if sulfonamides crystallize in the urinary tract (USP, 2003).  Tilmicosin 
administered by IV infusion is cardiotoxic, and IV tetracyclines can cause cardiovascular 
dysfunction and collapse due to hypotension (Gyrd-Hansen et al., 1981).  A very common 
deleterious effect of some antimicrobials such as florfenicol and ampicillin is an alteration in 
microbial gut flora (especially in calves), resulting in diarrhea (USP, 2003; CVP, 2005). 
Antimicrobial resistance (AMR):  The continued use of antimicrobials inevitably results in 
selection pressure favouring resistant organisms.  Even if the surviving AMR species are non-
pathogenic, plasmid-mediated transmission of AMR genes to pathogenic bacteria is a primary 
concern.  Resistant bacterial species are a risk not only for the animal who harbours them, but 
also for humans who may be exposed to these resistant species when eating animal-derived food 
products.  Regulatory agencies in the US currently require a risk assessment of AMR-emergence 
when reviewing new animal antimicrobial submissions.  Drug sponsors must demonstrate the 
rate and extent of development of AMR enteric bacteria in the animal’s gastrointestinal tract 
following exposure to a new animal drug (Tollefson, 2004).  Similar data is likely to be required 
in the future for new Canadian drug submissions as well. 
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Production and financial effects:  Using antimicrobials in cattle has direct consequences for the 
producer.  Milk and meat withdrawal times must be observed, which may result in lost revenue 
(discarded milk) or increased expenditures (extra feeding costs before slaughter).  The risk of 
incurring violative drug residues must be considered, which is especially punitive for dairy 
producers.  Irritating antimicrobial formulations such as long-acting oxytetracycline can cause 
injection site lesions, reducing the value of the carcass for the slaughter plant.  Finally, direct and 
indirect expenditures (the price of medication and labour costs) are incurred every time 
antimicrobials are used.   
 These adverse possibilities when using antimicrobials in cattle require the veterinarian 
and producer to continually perform cost/benefit analyses.  Are the consequences of infection 
severe for the animal (such as clostridial infections) or the producer’s finances (such as mastitis)?  
What is the likelihood of treatment success?  What are the risks of adverse drug reactions or 
toxicity?  Will this use contribute to AMR emergence?  What is the withdrawal period and cost 
of the drug?   
1.4.4  Perioperative use of antimicrobials 
 Because IP antimicrobial administration in cattle is only likely to occur during abdominal 
surgery, a brief discussion of the current principles governing perioperative antimicrobial use is 
warranted.  Any time surgery is performed there is a possibility of post-surgical infection.  
Healthy young patients with a competent immune system are unlikely to suffer infectious 
surgical complications.  Proper surgical site preparation, good surgical technique, sterile 
equipment and operating conditions, and minimal surgery time reduce the risk of postoperative 
infection (Brumbaugh, 1990; Nicholson et al., 2002; Giguere, 2006).  Some surgical procedures 
have greater risk of postoperative infection despite the best efforts of surgical staff.  Human 
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surgeries are divided into four classes based on the risk of surgical site infection, with a similar 
scheme applied to veterinary surgery (Table 2).   Prophylactic use of antimicrobials is also used 
routinely in both human (Bratzler & Houck, 2005) and veterinary medicine (Brown et al., 1997; 
Whittem et al., 1999; Weese & Halling, 2006) to reduce the likelihood of postoperative 
infections.  Current guidelines include the following recommendations (Gyssens, 1999; 
Zelenitsky et al., 2002; Bratzler & Houck, 2005; Howe & Boothe, 2006):  
• Use perioperative antimicrobials only when needed 
 
• Select the proper drug based on known or predicted efficacy against the likely pathogens 
to be encountered 
 
• Drug administration should occur before microbial contamination occurs, ideally at 
induction of anesthesia; and plasma drug concentrations should remain above the 
probable pathogen MIC throughout the operation but no longer.   
 
 The evidence that prophylactic antimicrobials reduce surgical infections in people is 
generally well accepted (Bratzler & Houck, 2005), although data from animal trials is mixed.  
Some studies show efficacy (Haven et al., 1992; Whittem, Johnson et al., 1999; Eugster et al., 
2004) but others demonstrate little or no benefit (Vasseur et al., 1985; Klein & Firth, 1988; 
Brown, Conzemius et al., 1997).  It may be inappropriate to compare results from multiple trials 
when the type and duration of surgery, skill of the surgeons, and local conditions differ between 
trials.  The optimal prophylactic antimicrobial dose regimen is not conclusively known.  
However, high plasma antimicrobial concentrations during incision and throughout the surgery 
are thought to prevent infections by reducing intraoperative bacterial counts below a critical 
threshold.  The patient’s immune system can then adequately respond to the remaining 
pathogens.  Prolonged duration of post-surgical antimicrobial therapy does not enhance success 
(Haven, Wichtel et al., 1992; Gyssens, 1999; Eugster, Schawalder et al., 2004; Giguere, 2006).   
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 Perioperative antimicrobial data is useful for bovine veterinarians as well, as surgery is a 
routine part of large animal veterinary practice.  Some procedures such as castrations and 
dehorning are relatively simple with little risk of infection.  More invasive abdominal surgery, 
including caesarian section, left or right displaced abomasum correction, exploratory laparotomy, 
and omphalophlebitis surgery, can be complicated by infectious processes; post-surgical 
infection rates for these procedures are reported to be 5 – 15% (de Kruif et al., 1987; Seger et al., 
1994; Desrochers et al., 1996; Bedard et al., 2001; Desrochers, 2005).  Notable differences 
between bovine surgery and routine human or small animal surgery include the following: 
Location:  Whereas nearly all human and small animal surgery is performed in sterile operating 
rooms with adequate staff, bovine surgery is generally performed in a chute in the veterinary 
clinic or on-farm, or outdoors with the cow restrained to a fence, tree, or tractor.  Sterility is 
exceptionally difficult to achieve in these situations as dust, flies, or manure may contaminate the 
surgery. 
Anesthesia:  Bovine abdominal surgery is performed under local or regional anesthesia, not 
general anesthesia.  Therefore the animal is more likely to move and cause breaks in sterility 
during surgery. 
Anatomy and physiology:  Abdominal surgery on cattle can be physically demanding on the 
surgeon because of the large size of the abdominal cavity and weight of the organs, increasing 
the risk of contamination.  Conversely, the ability of cattle to produce fibrin and wall off 
abdominal infections minimizes the negative systemic effects of peritoneal contamination.   
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Further details on perioperative antimicrobial use by bovine veterinarians are presented in 
Chapter 3.   
 
1.5  The Intraperitoneal (IP) Route of Drug Administration 
 
 Before presenting data from IP antimicrobial experiments in cattle, a general review of 
the IP route of administration is warranted.  Medications administered by IP infusion and 
resulting pharmacokinetics and efficacy are discussed. 
 
1.5.1  Anatomic considerations 
 
 The IP (also known as intra-abdominal) route of administration involves delivery of a 
substance directly into the abdominal cavity, but not into an abdominal organ.  The skin, 
subcutaneous tissue, abdominal musculature and peritoneum must be penetrated before reaching 
the abdominal cavity.  A ventral midline approach is often used in lab and small animals while in 
dorsal recumbency.  Medications can be administered IP in standing cows through the left or 
right paralumbar fossa.  Organs that may come in contact with the medication using this 
approach include the abomasum, rumen, small or large intestines, cecum, uterus, and bladder.  
The liver, omasum, and reticulum are generally located too far cranially to come in contact with 
IP infusions when using a paralumbar approach.   
 
1.5.2  Uses for IP administration 
 
Human:  Administration of IP antimicrobials is well documented in the literature for abdominal 
surgery and peritoneal dialysis.  ß-lactams (including piperacillin, cephalothin, cephazolin, 
ceftazidime, and cefoperazone) and aminoglycosides (kanamycin, gentamicin) are frequently 
mentioned (Ericsson et al., 1978; Stephen & Loewenthal, 1979; Okuda et al., 1986; Yelon et al., 
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1996; Sinswat et al., 2000; Wallet et al., 2000; Sisterhen et al., 2006).  Reports of IP 
clindamycin, lincomycin, vancomycin, and metronidazole use also exist (Stephen & Loewenthal, 
1979; Saha, 1985; Schwartz et al., 1986; Sisterhen, Stowe et al., 2006).  Other classes of drugs 
besides antimicrobials have been administered by IP infusion, including the antifungals 
amophotericin B and flucytosine and the anti-inflammatory/anti-endotoxic compound taurolidine 
(Arthur et al., 2004; Schneider et al., 2005).  
 
Cattle:  Experimental trials in cows have used IP infusions of oxytetracycline in saline, 
ampicillin/cloxicillin and kanamycin/penicillin preparations designed for intramammary use, and 
sodium ampicillin / ampicillin anhydrate (Fensterbank, 1976; Klein et al., 1989; Gitzel & 
Grunder, 1994; Klein et al., 1994).  Other compounds that have been deposited intraperitoneally 
in cattle include calcium EDTA (for the treatment of vanadium poisoning) and semen (for 
insemination). (Lopez-Gatius, 2000; Gummow et al., 2006)   
 
Other Animals: Various IP antimicrobials have been studied in other animal species, including 
dogs, rats, rabbits, and fish (Wieriks & Schornagel, 1971; Fry et al., 1986; Bruno, 1989; Ablan et 
al., 1991; Fairgrieve et al., 2006).   
 
1.5.3  IP Pharmacokinetics 
 
 The abdominal cavity has a large surface area and is highly perfused, in theory this 
should allow for rapid drug absorption.  Depending on the site of drug deposition within the 
abdomen, medication absorbed into the portal bloodstream passes through the liver before 
reaching the systemic circulation.  This potentially results in hepatic metabolism of drug before 
reaching the systemic circulation, known as “first-pass effect” (Benet, 1990).  Conversely, drugs 
absorbed into the parietal peritoneal blood vessels will not be subject to a first-pass effect.  
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Kinetic data after IP administration compared to other routes of administration is not available 
for most drugs.  Results from one bovine PK trial with IP administration include a Tmax of 20 min 
for sodium ampicillin and 1.0 h for ampicillin anhydrate (Klein, Firth et al., 1989).  Rapid 
absorption was found in one IP kanamycin study in humans, evidenced by a Tmax of 15 min 
(Ericsson, Jr. et al., 1978).  Other human trials with various antimicrobials had a Tmax range of 
0.5-5 h (Okuda, Katoh et al., 1986; Schwartz, Kowalsky et al., 1986; Sisterhen, Stowe et al., 
2006).    
 
1.5.4  Efficacy of IP use 
 
 The principle behind IP antimicrobial use during surgery is to achieve high local drug 
concentrations in the abdomen, where the infection/contamination occurs.  However, the lack of 
randomized trials with positive and negative controls (preoperative IV antimicrobial therapy and 
IP saline, respectively) makes it difficult to evaluate IP antimicrobial efficacy.  One retrospective 
study in cows showed a significantly lower rate of post-surgical infection after IP administration 
compared to cows given no antimicrobials (Klein, van der Velden et al., 1994).  No comparisons 
of intraoperative IP versus preoperative intravenous (IV) antimicrobials are available in cattle.  
The efficacy of IP antimicrobials in reducing infections after human abdominal surgery is 
inconclusive.  Some studies demonstrate efficacy (Yelon, Green et al., 1996), while others show 
no benefit over other treatment methods (Salvati et al., 1988; Schneider, Sack et al., 2005).  One 
trial in rabbits found an abdominal lavage containing a cephalosporin was more efficacious than 
saline alone for treating peritonitis, but only if the bacterial contamination was severe and the 
antimicrobial was administered promptly after contamination (Ablan, Olen et al., 1991).  An IP 
chlorhexidine lavage in mice reduced mortality after cecal puncture compared to cephalosporin 
and lactated ringer’s lavage groups (Bondar et al., 2000).   
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1.5.5  Contraindications of IP use 
 
 The IP route is generally considered non-irritating and safe in human medicine, although 
safety may be dependent on the antimicrobial formulation. Human IP medications are all IV 
formulations thoroughly diluted in an appropriate lavage/dialysis solution.  Veterinary literature 
does contain warnings about IP drug use, including chemical irritation of the peritoneum and 
adhesion formation after use of tetracycline, neomycin, and streptomycin (Withrow & Black, 
1979).  There was evidence of peritonitis in cows after IP infusions of ampicillin anhydrate but 
not sodium ampicillin (Klein, Firth et al., 1989).  Other antimicrobials and formulations have not 
been evaluated for irritability or safety in cattle. 
 
 
1.6  Project Goals 
 
 There is a lack of information in the scientific literature regarding the incidence, kinetics, 
residues and efficacy of IP antimicrobial use in cattle.  A series of research projects were 
designed to provide the data necessary to answer these questions: 
 
 1.  Review and update on-farm drug residue test kit data for dairy producers and 
veterinarians. 
 2.  Before embarking on IP pharmacokinetic (PK) or clinical trials, information was 
needed on the incidence of perioperative IP use by bovine veterinarians.  Although anecdotal 
reports of IP use are common, both through CgFARAD contacts and the American Association 
of Bovine Practitioners (AABP) listserve, information was needed to confirm that this practice 
does frequently occur.  This data could also be used to focus IP kinetics / efficacy experiments 
on the proper antimicrobials and doses.  A survey of Western Canadian Bovine Practitioners was 
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created to better understand perioperative antimicrobial use in general, with specific emphasis on 
IP administration. 
 3.  If it was determined that IP antimicrobial administration occurs frequently, a PK trial 
would be performed on the appropriate product(s).  Plasma drug concentrations, milk and meat 
residue depletion, and adverse drug reactions would be determined. 
 
 A project determining the clinical efficacy of IP antimicrobial administration would also 
be required to fully evaluate this practice.  However, financial and time restraints meant an 
efficacy trial was beyond the scope of this MSc thesis.  Nonetheless, we anticipated the novel 
data produced in the planned experiments would provide invaluable insight into the practice of 
IP antimicrobial use in cattle.  
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Table 1.1  Commonly used parenteral antimicrobials licensed in Canada for use in beef 
and/or dairy cattle  
Drug Class Generic Drug Trade 
names 
Rx  
OTC 
Beef / 
dairy  
Label Indications Route  
ß-lactams Penicillin Numerous OTC Both Respiratory disease 
Wound infections 
Foot rot 
Metritis 
Mastitis 
IM 
IMM 
Ampicillin Polyflex Rx Both Respiratory disease 
Enteritis 
IM, SC 
Ceftiofur Excenel Rx Both Respiratory disease 
Foot rot 
IM, SC 
Cephapirin Metricure Rx Both Metritis IU 
Cefa-Lak OTC Dairy Mastitis IMM 
Cloxacillin Dry-clox Rx Dairy Mastitis IMM 
Tetracyclines Oxytetracycline Numerous OTC Both Respiratory disease 
Foot rot 
Mastitis 
Metritis 
Enteritis 
Peritonitis 
Clostridial disease 
Joint infections 
IM, IV 
Macrolides Erythromycin Erythro-200 
Erythro-36 
Gallimycin 
OTC Both Respiratory disease 
Foot rot 
Mastitis 
IM,  
IMM 
Tylosin Tylan-200 OTC Beef Respiratory disease 
Metritis 
IM 
Tilmicosin Micotil Rx Beef Respiratory disease SC 
Lincosamides Pirlimycin Pirsue OTC Dairy Mastitis IMM 
Phenicols Florfenicol Nuflor Rx Beef Respiratory disease 
Foot rot 
Keratoconjunctivitis 
IM, SC 
Fluoroquinolones Enrofloxacin Baytril Rx Beef Respiratory disease SC 
 Danofloxacin A180 Rx Beef Respiratory disease SC 
Sulfonamides, 
potentiated 
Sulfadoxine + 
trimethoprim 
Trivetrin 
Borgal 
Rx Both Respiratory disease 
Enteritis 
Foot rot 
IM, IV 
Aminoglycosides Gentamicin Gentocin Rx Both Metritis IU 
Streptomycin  Ethamycin OTC Both Respiratory disease 
Leptospirosis 
IM 
Spectinomycin Adspec OTC Beef Respiratory disease SC 
Iodides Sodium iodide Sodide OTC Both Actinomycosis 
Actinobacillosis 
IV 
Rx = prescription only, OTC = over the counter 
IM = intramuscular, SC = subcutaneous, IV = intravenous, IMM = intramammary,  
IU = intrauterine 
Product monographs obtained from Compendium of Veterinary Products, 9th Ed. (CVP, 2005) 
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Table 1.2  Classification of surgical wounds based on probability of contamination and risk 
of surgical site infection (Giguere, 2006). 
 
Classification Criteria Approx. Risk 
Clean Non-traumatic; sterile technique; respiratory, 
GI, genitourinary tracts not entered. 
<5% 
Clean-contaminated Elective surgery on respiratory, GI, or 
genitourinary tracts with minimal 
contamination; minor break in sterility. 
5-10% 
Contaminated Contamination from GI tract; surgery into 
region already infected; major break in 
sterility; chronic open wound surgery. 
10-20% 
Dirty Encounter purulent material during surgery; 
perforation of respiratory, GI, or 
genitourinary tracts before surgery; 
penetrating trauma >4 h old. 
>20% 
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Chapter 2:  Milk Residue Testing 
 
 
      The dairy industry actively promotes milk and dairy products as safe and nutritious, and 
veterinarians play an important role ensuring residues of medications used on farm do not end up 
reaching the consumer.  Milk contaminated with antimicrobials is considered a public health 
hazard because of possible adverse reactions and antimicrobial resistance. Approximately 5-10 
percent of people are hypersensitive to penicillin (Dayan, 1993) and can potentially suffer 
allergic reactions if they ingest small quantities, including dermal reactions, asthma, or 
anaphylactic shock (Wicher, Reisman et al., 1969; Lindemayr, Knobler et al., 1981; Kanny, 
Puygrenier et al., 1994)   Despite these potential risks, confirmed cases of allergic reaction to 
penicillin in milk are extremely rare, and the residue issue is more a perceived than real problem 
(Sundlof, 1989; Dewdney, Maes et al., 1991; Dayan, 1993).  Another concern with antimicrobial 
residues in milk is a possible shift in antimicrobial resistance patterns in human enteric bacteria 
(Tollefson, 2006).  Although one can argue the relative risks (or lack thereof) of antimicrobial 
milk residues, what cannot be argued is the public demand for “wholesome” and “safe” food.  
Any publicity of drug residues in dairy products weakens consumer confidence, and the dairy 
industry and government agencies proactively ensure contaminated milk does not reach the 
market. From the milk processor’s perspective, antimicrobials also interfere with the 
manufacture of dairy products; concentrations of 1 ppb delay starter activity for cheese, butter, 
and yogurt.  These “inhibitors” also decrease the acid and flavor production associated with 
butter manufacture, reduce the curdling of milk, and cause improper ripening of cheeses (Jones, 
1999; Molina, Molina et al., 2003; Payne, Craigmill et al., 2006).  
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2.1  Drug Violations in Milk 
 
      In Canada, regulation of milk and dairy products is done on a provincial basis.  Results of 
residue testing are not readily available, and testing protocols may vary with jurisdiction and 
individual processors. In the province of Saskatchewan alone, the value of milk discarded due to 
antimicrobial drug residues is estimated to be $200,000 per year (Christensen, D.; personal 
communication).  A limited residue surveillance program is conducted by the Canadian Food 
Inspection Agency (CFIA).  In 2003/2004, 1,507 milk and cheese products were tested for 
antimicrobial residues with no positives detected (CFIA, 2004).  In comparison, mandatory test 
reporting is required by American state regulatory agencies under that National Conference on 
Interstate Milk Shipments. The Pasteurized Milk Ordinance (PMO) requires all bulk milk tankers 
to be sampled and analyzed for animal drug residues before the milk is processed. In addition, a 
minimum of four samples from pasteurized fluid milk and milk products must be tested from 
each plant every six months and each producer must be tested at least four times every six 
months (FDA, 2004).  In 2002/2003, over 4 million tests were conducted for antimicrobials, with 
2945 (less than <0.1%) positive  (NCIMS, 2004).  The violations resulted in the discard of 76 
million pounds of milk. The vast majority of residue violations were due to ß-lactam antibiotics, 
with a few sulfonamide and tetracycline violations.  
      Surveys indicate that improper use of drugs in the control of mastitis is the major source 
of residues in milk. The odds that a violative antimicrobial residue will be found in bulk tank 
milk increases with increasing somatic cell count (SCC) status of the herd (Ruegg & Tabone, 
2000; Saville, Wittum et al., 2000).  The SCC is an indicator of the prevalence of mastitis within 
a herd and such infections are routinely treated with antimicrobials in order to lower the SCC to 
acceptable levels.  High SCC is also associated with poor management practices; improper 
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antimicrobial use practices may contribute to the increased odds of a residue violation.  Drugs 
administered for dry cow therapy are unlikely to cause drug residues if milk is not shipped for 
the first four days after calving, if dry periods are longer than six weeks, and if dry cows are not 
accidentally milked.  
 
 
2.2  Maximum Residue Limits and Withdrawal times 
 
      When a drug is approved for use in a food animal species, regulatory authorities establish 
an acceptable daily intake (ADI). The ADI represents a level of daily intake of a drug which, 
during an entire lifetime, is without appreciable risk to the health of the consumer. The ADI is 
used to determine the maximum concentration of a marker residue in edible tissues, honey, milk, 
or eggs that is legally permitted or recognized as acceptable. In Canada and the European Union 
these acceptable concentrations are termed “maximum residue limits” (MRLs), and “tolerances” 
in the US. The MRL is calculated such that daily intake of food containing drug residues at the 
MRL will result in a total daily consumption of residues in quantities at or below the ADI.  The 
ADI is based on the total residue of a chemical present in food (parent compound and all 
metabolites), whereas MRLs are based on a single, measurable marker residue (which may be 
the parent compound or any of its metabolites). In establishing MRLs, consumption factors for 
the various foods are taken into account.  Therefore, foods consumed infrequently or in small 
amounts are allowed greater MRL values than those foods likely to be consumed daily or which 
represent a major component of the diet. Because of differences in consumption factors, MRLs 
may differ between countries; even if ADIs are equivalent (see Table 1) (VDD, 2003).  An 
example is ceftiofur, which has a Canadian MRL of 100 ppb in milk versus 50 ppb in the US.  
Canadian MRLs can be found at http://www.hc-sc.gc.ca/dhp-mps/vet/mrl-lmr/mrl-
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lmr_versus_new-nouveau_e.html.  Note that not all drugs licensed for use in dairy animals in 
Canada have an established MRL in milk, such as oxytetracycline (OTC) and cloxacillin.  In 
these cases, any drug residue detected constitutes a residue violation. 
      The milk withdrawal time (WDT) for a drug with a lactating dairy cow claim is based on 
the time required after treatment for milk residues to fall below the MRL in 99% of animals, 
95% of the time.  Differences may occur between label milk WDTs for the same product in 
Canada and the US.  In Canada there is no assumption regarding dilution of drug residues in the 
bulk tank, so when establishing a WDT milk from any individual cow must be below the legal 
MRL.  The Food and Drug Administration in the US assumes that no more than one-third of the 
milk in the bulk tank will come from treated cows. Therefore the label WDT is determined so 
that the milk from any treated cow will be less than 3 times the legal MRL (FDA, 1994).  
Veterinarians and producers must remember that US WDTs do not apply in Canada, as 
evidenced by intramammary pirlimycin (Pirsue®, Pfizer Animal Health) which has a 48 h milk 
withdrawal time in Canada but only 36 h in the US (CVP, 2005; CVP, 2005).  The milk WDT is 
not the point at which residues can no longer be detected.  Currently, milk WDTs are established 
using a quantitative chemical test as the milk screening tests do not have the required analytical 
characteristics to establish official WDTs. 
 
 
2.3  Elimination Kinetics 
 
 Drug elimination from a cow typically follows a characteristic pattern, in that the amount 
of drug eliminated per unit of time is proportional to the amount of drug present (1st order or 
linear kinetics). Because of this logarithmic nature of drug depletion, doubling a drug dose is not 
a major cause of residue violations, as doubling a dose only adds one elimination half-life to the 
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withdrawal time (Figure 2). However, giving label doses to a sick or geriatric cow significantly 
increases the risk for having a residue violation even if the label withdrawal time is followed.  
Pathology such as renal or hepatic dysfunction, dehydration, or hypoproteinemia can alter drug 
distribution and clearance.  These changes may prolong the elimination half life (T1/2 ELIM = 
0.693 x VD / ClS).  Variation in the half life can have profound effects on the WDT (Figure 2). 
      Improper injection techniques can cause violative residues even with label dosages. If 
slowly-absorbing formulations like procaine penicillin G are injected between muscle groups or 
given subcutaneously, the absorption is delayed (Papich et al., 1993). Most drugs will be 
absorbed more quickly and completely if given intramuscularly in the cow’s neck rather than the 
hindquarter muscles.  Injecting excessive drug volumes per site can also result in a decreased 
absorption rate and elongated withdrawal time. 
 
 
2.4  Drug Residue Testing 
 
      Drug residues in milk can be detected by several methods.  Most rapid, on-farm screening 
tests are microbial growth inhibition assays such as the Charm Farm Cowside (Charm Sciences 
Inc., Lawrence, Massachusetts, USA) and Delvotest SP (DSM Food Specialties, Delft, The 
Netherlands), or ELISA-based tests such as the IDEXX SNAP series (IDEXX Laboratories, 
Inc.,Westbrook, Maine, USA).  More expensive and bulky equipment used at processing plants 
includes the Charm II system (an immuno- or microbial receptor assay) and the Charm ROSA 
immunoassay (Charm Sciences Inc.).  Some screening test results can be assessed visually (a 
qualitative “yes or no”), while other systems incorporate semi-quantitative detectors.   
      Rapid antimicrobial screening tests are validated only for use with bulk tank or tanker-
truck milk samples.  Despite brand names that may include the term “cowside”, none of the tests 
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are currently validated for testing milk from individual cows. Likewise, no screening test is 
validated for sheep or goat milk, although certain tests appear adequate for this purpose 
including IDEXX SNAP ß-lactam, Delvotest, Charm Farm Cowside, and Charm II test kits 
(Zeng et al., 1998; Althaus et al., 2003).  To become certified by the Association of Official 
Analytical Chemists (AOAC), milk residue tests must pass rigourous evaluations for sensitivity, 
repeatability, and robustness.  Each test has a ninety percent sensitivity level (90/95) for specific 
drugs.  This is the estimated lowest concentration of that drug in milk that will give a positive 
result on 90% of truly positive samples, with 95% confidence (19 times out of 20).  For a test kit 
to be AOAC certified, this 90/95 number must be below the MRL (Europe) or tolerance (US) of 
the jurisdiction where the test is sold.  As well, drug residues at the MRL concentration must be 
detected with 100% sensitivity (all truly positive samples will test positive).  Because Canadian 
and American MRLs are not identical, some screening tests designed for the US market may not 
be ideal for use in Canada.  For example, the Charm Farm Cowside test has a sensitivity of 300 
ppb for oxytetracycline (OTC) in milk, the same as the US tolerance.  However, no MRL exists 
for OTC in milk in Canada and other tests can detect OTC at far lower concentrations, such as 
the IDEXX SNAP tetracycline test which can detect concentrations at or below 30 ppb.  
Therefore a Canadian dairy producer using the Charm Cowside test could inadvertently ship 
OTC-contaminated milk that may be detected if the plant uses a different test. 
      Because 90/95 levels must be below the MRL, screening tests can produce a positive 
result when the drug concentration is below the legal MRL.  These “subviolative” positive test 
results are positive test results on a milk sample in which the actual drug concentration is at or 
above the detectable concentration of the test, but below the established MRL.  With all of the 
tests, there is a characteristic response curve, which means that as the drug concentration 
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increases in the milk, there is a corresponding increase in the percentage of positive tests until a 
plateau is reached and all samples test positive. Even if two different tests have the same 90/95 
results at the MRL, the responses at less than MRL concentrations can differ. In the example in 
Figure 2, two test kits have almost exactly the same sensitivity level (7.5 ppb for Test A and 7.7 
ppb for Test B). But at the low penicillin concentrations, Test B gives a significantly greater 
percentage of positive test results. In Canada, depending on the provincial regulations and the 
contract between the producer and the processing plant, the label WDTs and legal MRLs for 
drugs used in dairy cattle are essentially meaningless. If provincial law or the contract states that 
there shall be no drugs in the milk, then the provincial authority or the processor is free to use 
any validated residue detection test, even if its 90/95 sensitivity level is far below what was 
determined to be safe for human consumption (the legal MRL). This is problematic for some 
drugs like ceftiofur and cephaprin (intrauterine formulations) that have zero milk WDTs on the 
label, but for which screening test sensitivity is far below the MRL that was used to establish the 
zero WDT. When evaluating the values for a screening test, the sensitivity is the concentration of 
the drug in the milk that the test will detect at the 90/95 level. If the sensitivity of the SNAP 
Beta-lactam test is 5.4 ppb for ceftiofur, then it will correctly detect 90% of samples that actually 
contain 5.4 ppb ceftiofur, 95% of the time.  But it is possible for the SNAP Beta-lactam test to 
detect as little as 1 ppb of ceftiofur in the milk on occasion – a subviolative positive at 1/100th of 
the legal MRL of 100 ppb. Also, rapid testing methods incorporating semi-quantitative visual 
detectors will give a range of actual readings at any single drug concentration. For example with 
Test B and a sample truly containing 6 ppb, repeating the test could give a range of readings 
from 4 to 12 ppb.  To determine the actual drug concentration of a sample, a truly quantitative 
method must be used such as high performance liquid chromatography (HPLC). 
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The issue with subviolative positives becomes more complicated when using multi-
residue tests such as the beta-lactam or sulfonamide screening tests. Each multi-residue test 
detects one or more drugs at concentrations below their respective MRL, but is not ideal for 
detecting all drugs (especially cloxacillin).  When testing for a known or suspected drug in milk, 
it is best to use a test that is designed specifically for that drug. When testing milk from cows 
where the treatment history is unknown, it is better to use a multi-drug screening test.  However, 
a positive result on a multi-drug test will not identify which specific drug is present.   
The rejection of subviolative but “safe” milk is an economic issue for dairy producers, 
who may not understand how they can use an approved drug according to label directions, follow 
the label WDT, and still have a residue violation. The regulatory authorities and processors know 
that these testing methods will result in a very small percentage of milk being dumped for testing 
positive, even though the drug residues are safe for human consumption (below the MRL) 
(CVM, 1996).  Identifying the specific drug and quantity present in a milk sample requires more 
specific chemical analysis, such as HPLC or mass spectrometry.  This is not feasible for every 
milk sample testing positive with a rapid screening test; due to the time and expense of 
witholding a positive milk tanker from the food supply until conclusive results are obtained.  The 
authorities accept the imprecision of the screening tests for the sake of the public good and the 
efficient delivery of milk products to consumers. 
 
 
2.4  Considerations When Choosing and Using Milk Residue Tests 
 
When recommending antimicrobial screening tests to clients, the sensitivity, cost, 
availability, and ease of use of the test must be considered.  In most cases, the choice should be a 
kit that tests as sensitive as possible, at least to the same concentration as the test that the 
34 
 
regulator or processor is using.  Different processors may use different tests, so it is important to 
know which method the processor is using. In Table 1, commercially available screening tests 
that are readily used “cowside” are compared according to their sensitivities for specific 
antimicrobials against the MRL values in the United States, Canada and the European Union.  
 High levels of natural inhibitors are present in mastitic milk and in colostrum;  they can 
cause false positive results in the microbial growth inhibition assays, such as Charm Farm 
Cowside or Delvtotest SP.  Heat treatment of milk to 82°C for 5 min inactivates natural 
inhibitors and can be used to prove false-positive results in the microbial growth inhibition 
assays (Kang et al., 2005).  High concentrations of milk protein and milk fat can adversely affect 
antimicrobial residue test performance, but the degree of the effect depends upon the analytical 
method of the screening test (Andrew, 2000). Higher concentrations of immunoglobulins and 
milk protein can also cause false positives with screening tests used on samples from recently 
freshened heifers or cows (Andrew, 2001). 
Because rapid milk residue tests will only detect certain antibiotics or classes of 
antimicrobials, veterinarians should review farm drug use with their clients so an appropriate test 
can be recommended.  If more than one drug is given, a single test may not be adequate to ensure 
that the milk is free of detectable residues. Despite the fact that test kits are not validated for 
individual animals, milk from all sick or dehydrated cows that have been treated with 
antimicrobials should be tested, even if label instructions were followed.  If there is no suitable 
on-farm test available, the producer should ask the processor to check a milk sample before 
adding milk from a treated cow to the bulk tank.  Rapid screening tests do not detect drugs other 
than antimicrobials; however, the CFIA does carry out quantitative testing for other drugs and 
chemicals, including flunixin, ivermectin, phenylbutazone, and pesticides.  
35 
 
Most of the screening tests use a color comparison against a control to indicate a positive 
or a negative test result. The test operator must be able to distinguish between intensities of color 
for accurate results. While they tend to be expensive, we recommend purchasing the electronic 
reader if it is available with a screening test. Otherwise, any milk with a questionable result 
should be discarded and the cow re-sampled at the next milking. Clients must be warned that 
screening tests are not meant to shorten the official milk WDT.  As well, producers should not 
dilute “positive” milk by adding it to the bulk tank milk as the actual amount of drug present 
cannot be quantified with the screening test.  One cannot be certain that diluting the positive milk 
will be sufficient, and the entire bulk tank may end up contaminated.  During our recent 
penicillin studies, one dose of 21,000 IU/kg procaine pen G administered via intraperitoneal 
infusion resulted in penicillin concentrations in milk of nearly 400 ppb 6 h later (see Chapter 4 
for further details).  Even if diluted with milk from 100 untreated cows, the bulk tank penicillin 
concentration (4 ppb) would still be detected by most screening tests.    
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Figure 2.1 Milk Residue Depletion Curves 
 
Milk residue concentration vs time
1
10
100
1000
0 12 24 36 48 60 72 84 9
Time (h)
D
ru
g 
C
on
ce
nt
ra
tio
n 
(p
pb
)
6
Normal dose
Double dose
disease state
6 h
6 h
12 h
For the normal dose in a healthy cow (solid line), drug concentration in milk decreases by one-
half every 6 h.  Assuming the MRL is 1 ppb, the drug will have a WDT of approx. 46 h.  
Doubling the dose (--- --- ---) results in the same half-life (6 h).  The WDT will be one half-life 
longer (approx. 52 h).  If disease processes affect drug distribution or clearance, a longer half-life 
may result (-  -  -  -).  Although the dose was the same as the normal treatment, doubling the 
elimination half-life effectively doubles the withdrawal time, in this case to 92 h. 
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Figure 2. Test Sensitivity Curves 
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Test A and Test B have similar 90/95 sensitivities at penicillin concentrations of 10 ppb, but Test 
B is more likely to have subviolative positive results at concentrations less than 10 ppb.  
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Table 2.1 Comparison of commercially available on-farm screening tests for antimicrobials 
(as of December 2006) 
Drug Test Sensitivity 
(ppb) 
US MRL 
(ppb) 
CDN MRL 
(ppb) 
EU MRL
(ppb) 
Amoxicillin Charm Farm Cowside 6 10 NE 4 
 Delvotest P 6    
 IDEXX SNAP B-lactam 7.3    
Ampicillin Charm Farm Cowside 5 10 10 4 
 Delvotest P 5.8    
 IDEXX SNAP B-lactam 5.8    
Ceftiofur Charm Farm Cowside 300 50 100 100 
 Delvotest P 50-70    
 IDEXX SNAP B-lactam 5.4    
Cephapirin Charm Farm Cowside 10 20 20 10 
 Delvotest P 7    
 IDEXX SNAP B-lactam 11.7    
Chlortetracycline Charm Farm Cowside 300 300 NE 100 
 Delvotest P 300    
 IDEXX SNAP Tetracycline 30    
Cloxacillin Charm Farm Cowside 30 10 NE 30 
 Delvotest SP 20    
 IDEXX SNAP B-lactam 50    
Dicloxacillin Charm Farm Cowside 25 NE NE 30 
 Delvotest P/SP 100    
 IDEXX SNAP B-lactam 50    
Erythromycin Charm Farm Cowside 150 50 50 40 
 Delvotest SP 250    
Gentamicin Charm Farm Cowside 300 30 NE 100 
 IDEXX SNAP Gentamicin 30    
 Delvotest SP 400    
Lincomycin Charm Farm Cowside 200 150 NE 150 
 Delvotest SP 400    
Neomycin Delvotest P 150 150 NE 500 
Novobiocin Delvotest P/SP 600 100 NE 100 
Oxytetracycline Charm Farm Cowside 300 300 NE 100 
 Delvotest P 300    
 IDEXX SNAP Tetracycline 30    
Penicillin Charm Farm Cowside 4 5 10* 4 
 Delvotest SP 2.7    
 IDEXX SNAP B-lactam 3.0    
Pirlimycin Charm Farm Cowside 200 400 400 100 
 Delvotest SP 50    
Polymixin B Delvotest P 30 0 4 NE 
Sulfonamides Charm Farm Cowside 20-200 10 10 100 
 Delvotest SP 100    
Tetracycline Charm Farm Cowside 100 300 NE 100 
 Delvotest P 300    
 IDEXX SNAP Tetracycline 20    
Tilmicosin Charm Farm Cowside 100 0 NE 40 
Tylosin Charm Farm Cowside 100 50 NE 50 
 Delvotest P/SP 100    
NE: no legal maximum residue limit established, * MRL value is in IU/mL 
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Chapter 3:  A survey of antimicrobial use during bovine abdominal surgery 
by Western Canadian veterinarians  
 
3.1  Abstract 
 Members of the Western Canadian Association of Bovine Practitioners were surveyed 
regarding their use of antimicrobials in bovine abdominal surgery.   Perioperative antimicrobials 
were used in 100% of abdominal surgeries by 96 of 98 respondents.  Although postoperative 
administration was the most common perioperative period for antimicrobial use, intraoperative 
intraperitoneal (IP) use was reported by more than half of the veterinarians surveyed.  Procaine 
penicillin G and oxytetracycline were the most commonly administered perioperative 
antimicrobials.   
 
3.2  Introduction 
 The Canadian global food animal residue avoidance databank (CgFARAD) has received 
many requests for meat and milk withdrawal recommendations after perioperative extra-label use 
of antimicrobials, including the intraperitoneal (IP) or intra-abdominal infusion of antimicrobials.  
Due to the unhygienic operating conditions often encountered during ambulatory surgeries, many 
veterinarians choose to administer perioperative antimicrobials.  Gram-positive staphylococci, 
Gram-negative enteric bacteria, and anaerobes are all potential contaminants during ambulatory 
bovine surgery.  In human medicine, current guidelines call for prophylactic antimicrobials to be 
selected based on predicted efficacy against probable pathogens and administered before 
microbial contamination occurs (Gyssens, 1999; Zelenitsky, Ariano et al., 2002).  The success of 
preoperative antimicrobial prophylaxis has also been demonstrated in bovine surgery (Haven, 
Wichtel et al., 1992).  However, due to withdrawal times required for most antimicrobials used 
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in cattle, presurgical antimicrobials may be withheld if the prognosis is uncertain and the animal 
is to be salvaged for slaughter.  Following successful corrective surgery, practitioners may opt to 
administer antimicrobials directly into the abdomen. 
 The IP route is employed in human abdominal surgery and peritoneal dialysis, with 
cephalosporins and aminoglycosides commonly used (Ericsson, Jr. et al., 1978; Okuda, Katoh et 
al., 1986; Yelon, Green et al., 1996).  All reports cite antimicrobial formulations suitable for 
intravenous use that are thoroughly diluted in appropriate lavage/dialysis solutions.  The efficacy 
of IP antimicrobials in reducing infections after human abdominal surgery has not been proven 
decisively.  The kinetics of IP antimicrobials in humans are variable, with maximum plasma 
concentrations occurring from 15 min - 5 h after administration for various antimicrobials 
(Ericsson, Jr. et al., 1978; Okuda, Katoh et al., 1986; Schwartz, Kowalsky et al., 1986).  
Intraperitoneal antimicrobials are also used in animal species, including dogs, rabbits, and fish 
(Fry, Trachtenberg et al., 1986; Bruno, 1989; Ablan, Olen et al., 1991; Fairgrieve, Masada et al., 
2006).  One trial in rabbits found that an abdominal lavage containing a cephalosporin was more 
efficacious than saline alone for treating peritonitis, but only if the bacterial contamination was 
severe and the antimicrobial was administered promptly after contamination (Ablan, Olen et al., 
1991).  Experimental trials in cows have used IP infusions of oxytetracycline in saline and 
ampicillin/cloxicillin and kanamycin/penicillin preparations designed for intramammary use 
(Fensterbank, 1976; Gitzel & Grunder, 1994; Klein, van der Velden et al., 1994).  One 
retrospective study showed a lower rate of post-surgical infection after IP administration 
compared to cows not given antimicrobials (Klein, van der Velden et al., 1994).  However, 
comparisons against pre-operative intravenous (IV) prophylaxis are lacking.  
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 Although the IP route is generally considered non-irritating and safe in human medicine, 
the formulation of the antimicrobial may play an important role.  There is evidence of peritonitis 
in cows after IP infusions of an ampicillin anhydrate formulation, but not of sodium ampicillin 
(Klein, Firth et al., 1989).  Other antimicrobials and formulations have not been evaluated for 
peritoneal inflammation or safety.  Another issue that has not been addressed in cattle is 
withdrawal times after IP administration.  Because this practice is extra-label, practitioners have 
contacted CgFARAD for advice regarding meat and milk withdrawal times.  Unfortunately, 
insufficient data is available in the literature to develop an informed withdrawal interval 
estimate.  The CgFARAD has received anecdotal reports of cows with penicillin-positive milk 
samples for weeks after perioperative IP use, although cows given ampicillin by IP infusion had 
positive milk tests for only 24-96 hours, depending on the formulation (Klein, Firth et al., 1989).  
Tissue residue depletion kinetics in cows are not available, although a 1955 study found residues 
in muscle, kidney, and liver in bulls given IP oxytetracycline one hour before slaughter (Kersey 
et al., 1955).  As well, trials using IP injections of oxytetracycline and macrolides in salmon 
found detectable drug residues in various tissues up to 8 weeks later (Bruno, 1989; Fairgrieve, 
Masada et al., 2006).   
 The frequency of IP antimicrobial administration during bovine surgery has not been 
reported.  Before pursuing a kinetic trial to evaluate this practice, we surveyed members of the 
Western Canadian Association of Bovine Practitioners (WCABP) on their antimicrobial use 
during bovine abdominal surgery. The objective was to determine the frequency and specifics of 
perioperative antimicrobial use by bovine veterinarians, with special emphasis on IP use. 
 
 
42 
 
3.3  Materials and Methods 
Survey Design 
 In June of 2005, surveys were mailed to all 240 members of the WCABP, a voluntary 
membership organization representing mixed and large animal veterinarians practicing beef 
and/or dairy medicine in the 4 Western Canadian provinces.  Surveys were mailed along with 
pre-paid return envelopes as part of the WCABP quarterly newsletter.  The survey was designed 
by two of the authors (AC, PD) and reviewed by one clinician at the Western College of 
Veterinary Medicine large animal clinic. Respondents were asked to record the percentage of 
cattle undergoing abdominal surgery they treated with antimicrobials at each of three surgical 
periods (preoperative, postoperative, or intraoperative IP).  Although data regarding IP use was 
the primary motivation for the survey, preoperative and postoperative antimicrobial use 
questions were included to give perspective on IP use compared to other time periods of 
perioperative antimicrobial use.  Veterinarians were also asked to list which drug(s) they 
commonly used at each surgical time frame and what dose and route of administration were 
used.  Trade or generic names of antimicrobials were accepted.  Because IP use of antimicrobials 
is extra-label, meat and milk withdrawal intervals (WDI) recommended by the veterinarian after 
IP use were also asked.  See Figure 1 for a sample survey response. 
Statistical Analysis 
 As the data were non-normally distributed, a Kruskal-Wallis one-way analysis of 
variance was used to test for significant differences between frequency of antimicrobial use for 
each surgical period (α=0.05).  Post-hoc comparisons were performed with Wilcoxan Rank Sum 
tests and Bonferroni’s correction.  Data was analyzed using a commercial software package 
(Statistix Version 8, Analytical Sotfware, Tallahassee, FL). 
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3.4  Results 
Response rate and data tabulation:  Survey responses were received for 6 weeks after mailout. 
The survey response rate was 40.8% (98/240).  As responses were anonymous, no specific 
follow-up with non-respondents or respondents was possible. A general follow-up to all survey 
recipients was not performed.  Drugs were categorized according to their generic formulation, 
regardless of brand.  Frequencies of antimicrobial administration were combined into the 
following categories: Never (0%), Rarely (1-24%), Sometimes (25-74%), and Frequently (75-
100%). Since there were few respondents that identified use as either 25 – 50 % or 50 – 74% 
these responses were combined in the ‘Sometimes’ category.   
   
Perioperative antimicrobial use:  Of the 98 respondents, 96 treated all cattle with some type of 
perioperative antimicrobial.   Seventy-nine of 98 respondents administered postoperative 
antimicrobials to at least 75% of their surgical patients.  Intraoperative IP antimicrobial use was 
reported by 54 of 98 respondents at least some of the time, with 30 of 98 respondents using IP 
antimicrobials frequently (≥ 75% of their surgeries).  Forty-four of 98 respondents never utilized 
IP antimicrobials.  Those using IP antimicrobials reported a frequency of administration ranging 
from 1 – 100% of surgeries.  Preoperative antimicrobials were administered frequently by 18/98 
respondents, while a slight majority (52/98) of respondents never administered preoperative 
antimicrobials before bovine abdominal surgery.  There was a significant difference (p < 0.001) 
between the frequency of postoperative administration versus preoperative and IP administration.   
No significant difference between the frequency of preoperative and IP administration was 
observed. 
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Types and doses of antimicrobials used:  The antimicrobials predominantly used perioperatively 
by the survey respondents are shown in Figure 2.  Overall, penicillin and oxytetracycline were 
the most commonly used antimicrobial at each perioperative period.  Other antimicrobials used 
include chlorhexidine (IP, n=1), nitrofurazone (IP, n=1), and sulfamethazine (IP, n=1; 
postoperative, n=1).   Doses of preoperative and postoperative antimicrobials closely followed 
manufacturer’s label recommendations.  Doses of the IP antimicrobials used predominantly were 
similar to the label IM/SC dose (n=28), with 8 respondents using more and 3 using less than the 
label dose.  
 
IP meat and milk withdrawal intervals:  Withdrawal intervals (WDIs) recommended by 
respondents after IP administration of various antimicrobials are shown in Figures 3a and 3b.  
WDIs ranged from 3-14 days (n=14) for penicillin in milk, 3-60 days (n=5) for oxytetracycline 
in milk, and 5-120 days (n=51) for various antimicrobials in meat.  Thirteen of 14 respondents 
recommended a milk WDI of 96 hours or more after using penicillin IP, and 5/5 recommended 
72 hours or more after IP oxytetracycline LP use.  Meat WDIs were ≥ 10 days for 23/25 
respondents who used IP penicillin, and 9/11 respondents recommended ≥ 18 days after IP 
oxytetracycline use.   
 
3.5  Discussion 
 The purpose of this survey was to develop a better understanding of the current 
perioperative antimicrobial practices of bovine veterinarians in Western Canada, with specific 
emphasis on intraperitoneal (IP) use.  Members of the Western Canadian Association of Bovine 
Practitioners (WCABP) were chosen to receive this survey as they were deemed representative 
of bovine practitioners in Western Canada.  Although approximately 27% of veterinarians in 
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Western Canada performing bovine work are members of the WCABP, we felt this was a 
representative sample of bovine veterinarians.  Few veterinary clinics have more than one 
WCABP member, so clustering of responses by clinic would be minimized in this study.  
Potential biases may be present in the survey results.  Antimicrobial usage by WCABP members 
may not mirror that of non-WCABP bovine practitioners, or that of the WCABP members who 
did not respond to the survey.   A lack of central information on other veterinarians practicing 
bovine medicine in Western Canada precluded sending surveys to non-WCABP members. 
 Interpretation of survey results was also limited by other factors.  Veterinarians who 
routinely use perioperative antimicrobials may have been more likely to respond than non-users.  
The percentage of surgeries receiving antimicrobial treatment was likely a “best guess” and may 
have been under- or over-estimated. As respondents were instructed to write their specific 
antimicrobial choices and dose regimens, answers were sometimes ambiguous.  Respondents 
were not asked information on personal and practice details that might affect antimicrobial 
usage, such as veterinary school attended, year of graduation, or how their perioperative regimen 
was established. However, despite these difficulties a number of observations can be made from 
the data.   
 Perioperative antimicrobial use is routine during bovine abdominal surgery, as nearly all 
respondents treated all of their bovine abdominal surgeries with an antimicrobial.  The most 
common surgical period for antimicrobial administration in this group of respondents was 
postoperatively, despite limited evidence of efficacy compared to preoperative administration 
(Haven, Wichtel et al., 1992).  It is unknown why practitioners continue to favour this practice 
when other alternatives appear more effective.  Perhaps the evidence of limited efficacy has not 
reached practitioners or empirical surgical success leads them to believe postoperative therapy is 
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beneficial.  One possible reason for the relatively low frequency of preoperative antimicrobial 
use is the unwillingness to incur a withdrawal time if the surgical prognosis is poor and the 
animal will instead be sent to slaughter.  Some drugs used preoperatively in this survey are long-
acting formulations (such as oxytetracycline LA or benzylpenicillin) that do not achieve 
therapeutic plasma concentrations by the time surgery is underway (Papich et al., 1994; 
Craigmill et al., 2004).  
 Intraperitoneal (IP) antimicrobial use also occurred during bovine abdominal surgery.  
Though the frequency of IP use in individual animal surgeries cannot be reliably estimated from 
this survey, enough respondents indicated frequent IP use (30/98 responses use it during ≥ 75% 
of their surgeries) to conclude that this practice is not an isolated occurrence.  Possible rationales 
for IP use include ease of administration, perceived quicker absorption than intramuscular or 
subcutaneous injections, and a perceived local antimicrobial effect.  However, IP kinetic data is 
limited and a local (peritoneal) antimicrobial effect has not been proven.   
 The majority of WDIs recommended after IP antimicrobial administration were longer 
than the manufacturer’s label withdrawal time (WDT) after intramuscular (i.m.) use of the same 
drug.  Respondents were not specifically asked whether on-farm drug residue milk tests were 
used, or if CgFARAD was contacted for a withdrawal recommendation.  A large number of “not 
applicable” responses were given for milk withdrawal recommendations, presumably because 
the surgeries were performed on beef cattle. 
 Procaine penicillin G and oxytetracycline were the most commonly administered 
perioperative antimicrobials.  However, some clearly inappropriate drugs were administered 
perioperatively as well.  These include the IP use of neomycin (inappropriate spectrum of 
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activity, chemical irritation, and prolonged residues due to renal accumulation), nitrofurazone 
(banned in food producing animals), and chlorhexidine (chemical irritation). 
 Perioperative antimicrobial use was practiced by the majority of WCABP members who 
responded to this survey.  Postoperative administration was the most common perioperative 
period for antimicrobial use, but IP use was reported to occur in at least some surgeries by more 
than half of the respondents.  Information on IP antimicrobial use provided by this survey has 
guided the specific direction of the authors’ ongoing IP antimicrobial pharmacokinetic trials.   
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Figure 3.1 Perioperative antimicrobial survey sample response. 
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Figure 3.2  Frequency of perioperative antimicrobial administration by type of 
antimicrobial and time of administration   
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Figure 3.3 Milk and meat withdrawal intervals (WDIs) recommended by veterinarian after 
IP use of primary antimicrobials  
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PPG = procaine penicillin G 
Oxytet LP = oxytetracycline LP (short acting) 
Vertical arrows indicate manufacturer’s label withdrawal time (WDT) after intramuscular (IM) 
administration.  Empty arrow = oxytetracycline LP:  WDT, 3 d (milk), 18 d (meat).  Solid arrow 
= procaine penicillin G:  WDT, 4 d (milk), 10 d (meat).  Neomycin is not labeled for parenteral 
use in cattle and does not have an established milk or meat withdrawal time.  N/A = not 
applicable (no milk WDI given for beef cattle). 
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Chapter 4:  Pharmacokinetics and residues after IP administration of 
procaine penicillin G in lactating dairy cows 
 
 
4.1  Abstract  
 
 This study describes the pharmacokinetic profile of procaine penicillin G after 
intraperitoneal (IP) administration in 8 lactating dairy cows.  Procaine pencillin G (PPG, 21,000 
IU/kg) was deposited into the abdominal cavity of each cow following an incision in the right 
paralumbar fossa.  Blood and milk samples were taken over the following 10 days, at which 
point the cows were euthanized.  Plasma, milk, muscle, liver, and kidney penicillin 
concentrations were determined by HPLC, with a limit of detection (LOD) of 5 ppb for plasma 
and milk samples.  Noncompartmental methods were used to analyze plasma kinetics.  The mean 
pharmacokinetic parameters (± s.d.) were: Cmax, 5.5 ± 2.6 μg/mL; Tmax, 0.75 ± 0.27 h; AUC0-∞, 
10.8 ± 4.9 μg*h/mL; MRT, 2.2 ± 0.9 h.  All milk from treated cows contained penicillin residues 
for a minimum of 3 milkings (31 h) and maximum of 5 milkings (52 h) after administration.  
Concentrations of penicillin G in all muscle, liver, and kidney samples taken 10 days post-
administration were below the limit of detection.  Necropsy examinations revealed foci of 
hemorrhage on the rumenal omentum of most cows but peritonitis was not observed.  Systemic 
inflammation as determined by altered leukograms and fibrinogen was noted in one cow.  The 
results of this study demonstrate that IP procaine penicillin G is absorbed and eliminated rapidly 
in lactating dairy cows. 
 
4.2  Introduction 
 Caesarian sections, left or right displaced abomasums, exploratory laparotomies, and 
umbilical hernia repairs are common indications for abdominal surgery in bovine practice.  The 
risk of surgical infection is elevated after on-farm surgery due to the nature of abdominal surgery 
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(clean-contaminated, contaminated, or dirty); and the non-sterile operating conditions 
encountered.  In addition to observing proper surgical site preparation, minimal surgery time, and 
good surgical technique, veterinarians can administer perioperative antimicrobials in an effort to 
reduce post-surgical infections (Brumbaugh, 1990; Desrochers, 2005).  In veterinary teaching 
hospitals, post-surgical infection rates of 5-15% for bovine abdominal surgeries are reported (de 
Kruif, van den Brand et al., 1987; Seger, Grunert et al., 1994; Desrochers, St-Jean et al., 1996; 
Bedard, Desrochers et al., 2001; Desrochers, 2005).  “On-farm” rates are likely higher.  Gram-
positive staphylococci (from skin or environment), Gram-negative enteric bacteria (from fecal 
contamination), and anaerobes (from necrotic tissue) are potential contaminants during bovine 
surgery.  Unfortunately, cultures and susceptibilities of the bacteria causing post-surgical 
infections are not routinely performed.   
 Current guidelines in human and veterinary medicine recommend prophylactic 
antimicrobials based on predicted efficacy against probable pathogens with administration before 
microbial contamination occurs (Gyssens, 1999; Zelenitsky, Ariano et al., 2002; Giguere, 2006; 
Howe & Boothe, 2006).  The benefits of preoperative versus postoperative administration have 
also been demonstrated in bovine surgery (Haven, Wichtel et al., 1992), where one preoperative 
dose of intravenous (IV) penicillin was as efficacious as the preoperative dose plus a 7-day 
postoperative course of intramuscular (IM) penicillin in reducing post-rumenotomy 
complications. Both groups had lower rectal temperatures and fewer abscesses than non-treated 
animals.  If an infection becomes established however, a longer course of antimicrobial therapy 
is warranted.  Calves undergoing contaminated umbilical hernia surgery were less likely to have 
post-operative infections if treated with IM penicillin and dihydrostreptomycin for 4 days 
postoperatively rather than just one (Klein & Firth, 1988).    
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 Using preoperative antimicrobials in surgical cases where the prognosis is uncertain 
precludes the possibility of salvaging the animal for slaughter because a withdrawal time must be 
observed.  In such cases, practitioners may administer antimicrobials directly into the abdomen 
(intraperitoneal, IP) upon successful completion of the abdominal surgery.  The IP route is 
commonly employed in human abdominal surgery and peritoneal dialysis, using ß-lactams 
(cephalothin, cephazolin, ceftazidime) and aminoglycosides (kanamycin, gentamicin) (Ericsson, 
Jr. et al., 1978; Stephen & Loewenthal, 1979; Okuda, Katoh et al., 1986; Yelon, Green et al., 
1996; Sinswat, Wu et al., 2000; Sisterhen, Stowe et al., 2006).  Other reports mention IP use of 
macrolides, vancomycin, metronidazole, and the antifungals amophotericin B and flucytosine 
(Saha, 1985; Schwartz, Kowalsky et al., 1986; Arthur, Drew et al., 2004).   
 Because the frequency of IP antimicrobial use in cattle has not previously been reported, 
the authors surveyed bovine veterinarians in Western Canada.  Perioperative antimicrobial use 
was widespread (96/98 respondents), with 54/98 practitioners surveyed using IP antimicrobials 
occasionally.  Of those, 30/98 used IP antimicrobials in ≥ 75% of their abdominal surgeries 
(Chicoine, 2007).  Procaine penicillin G and oxytetracycline LP were the most commonly used 
IP antimicrobials.  Veterinarians assumed IP antimicrobial administration is safe and that the 
drug is absorbed faster than IM or SC injections, though little PK data in cattle is available to 
support this assumption.  The kinetics of IP antimicrobials in humans are variable, with 
maximum plasma concentrations occurring from 15 minutes to 5 hours after administration for 
various antimicrobials (Ericsson, Jr. et al., 1978; Okuda, Katoh et al., 1986; Schwartz, Kowalsky 
et al., 1986).   
 Bovine experimental trials using IP infusions of oxytetracycline in saline and 
intramammary (IMM) ampicillin/cloxicillin and kanamycin/penicillin preparations have been 
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performed (Fensterbank, 1976; Gitzel & Grunder, 1994; Klein, van der Velden et al., 1994).  
One retrospective study showed a lower rate of post-surgical infection after IP antimicrobial 
administration compared to untreated cows (Klein, van der Velden et al., 1994).  Unfortunately, 
comparisons against pre-operative intravenous (IV) prophylaxis are not available.  IP 
antimicrobials are also used in other animal species, including dogs, rats, rabbits, and fish 
(Wieriks & Schornagel, 1971; Fry, Trachtenberg et al., 1986; Bruno, 1989; Ablan, Olen et al., 
1991; Fairgrieve, Masada et al., 2006).  The efficacy of IP antimicrobials in reducing infections 
has not been proven decisively; some studies demonstrate efficacy while others show no benefit 
over irrigation with saline alone.  One trial in rabbits found that an abdominal lavage containing 
a cephalosporin was more efficacious than saline alone for treating peritonitis, but only if the 
bacterial contamination was severe and the antimicrobial was administered promptly after 
contamination (Ablan, Olen et al., 1991). 
 Because IP antimicrobial administration constitutes extralabel drug use, practitioners 
have contacted the Canadian global Food Animal Residue Avoidance Databank (CgFARAD) for 
advice regarding meat and milk withdrawal times.  Unfortunately, insufficient data is available in 
the literature to develop a withdrawal interval estimate.  The CgFARAD has anecdotal reports of 
cows with penicillin-positive milk samples for weeks after IP penicillin administration, although 
cows given ampicillin by IP infusion had positive milk tests for only 24-96 hours, depending on 
the formulation (Klein, Firth et al., 1989).  Tissue residue depletion kinetics in cattle after IP 
antimicrobial administration are not available, but residues were detected in muscle, kidney, and 
liver in bulls given IP oxytetracycline one hour before slaughter (Kersey, McMahan et al., 1955).  
Trials using IP injections of oxytetracycline and macrolides in salmon found detectable drug 
residues in various tissues up to 8 weeks later (Bruno, 1989; Fairgrieve, Masada et al., 2006).   
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 The purpose of this study was to determine the plasma pharmacokinetics of penicillin in 
lactating dairy cows after the administration of 21,000 IU/kg procaine penicillin G via IP 
infusion.  Milk and meat penicillin residues would also be determined and any adverse reactions 
evaluated. 
 
 
4.3  Materials and methods 
 
Animals:  A total of 9 cull, lactating Holstein cows were purchased from a local dairy farm in 3 
groups, with 3 cows per group.  Cows were culled for reproductive failure (n=6), decreased milk 
production (n=2), or lameness (n=1).  Cows were housed in stanchions at the Western College of 
Veterinary Medicine (WCVM) large animal clinic for the duration of the trial and were fed a diet 
of alfalfa/grass hay and total mixed ration (TMR).  Water was freely available.  The mean age 
and days in milk (n=8) were 5.2 ± 1.6 y (range 2.3 – 7.9 y) and 292 ± 184 d (range 38 -642 d).  
Mean milk production during the current lactation had been 20.5 ± 5.3 kg/d.  The cows’ 
estimated weights (using a weight tape measure) ranged from 500 – 700 kg (mean 650 kg).  
Cows were milked twice daily with a portable vacuum milking machine for the duration of the 
trial.  All cows were free of mastitis for at least 3 months before the trial began.  No cows used in 
the study had undergone prior abdominal surgery.  The study protocol was approved by the 
University of Saskatchewan Animal Care Committee.   
 
Drug administration:  IP penicillin administration was designed to mimic a typical dose during 
bovine abdominal surgery.  A paravertebral infusion of lidocaine, 40 mL per site at the cranial 
border of L1 – L3 was used for local anesthesia of the right flank.  The right paravertebral fossa 
was clipped and aseptically prepared for surgery.  For cows A, B, and C, a 3 cm incision was 
made in the skin followed by insertion of a sterile teat canula through the abdominal muscle 
56 
 
layers to minimize surgical trauma.  The cannula was inserted through the peritoneum, negative 
air pressure was ascertained audibly, and 21,000 IU/kg (13.1 mg/kg) procaine penicillin G (Pen 
Vet 300, Rafter 8 Products, Calgary, AB, Canada) was infused through the cannula.  After 
determining that penicillin concentrations were negligible in milk and plasma of cow A (but 
easily detectable in cows B and C), it was speculated that the penicillin may have been infused 
into the rumen instead of the abdominal cavity.  The blind teat cannula approach was replaced in 
cows D – I by a full surgical incision through the muscle layers and peritoneum, with 
visualization of the abdomen before penicillin was infused (Figure 4.1).  Peritoneum, muscle, 
and skin layers were closed with routine surgical methods. 
 
Blood collection:  A jugular catheter was placed in each cow prior to surgery to facilitate blood 
collection.   Blood was drawn into a syringe and transferred into 50 mL polypropylene centrifuge 
tubes containing 500 IU sodium heparin.  Samples were taken at 0, 0.5, 1, 2, 3, 4, 6, 8, 12, 24, 
36, 48, 60, and 72 h following the IP administration of penicillin.  The blood samples were 
refrigerated for < 8 h until centrifuged at 1500 X g for 15 m.  Plasma was harvested and stored at 
-20°C until analysis.  Samples were analyzed within 21 days of collection.  Blood samples were 
also submitted for complete blood count and/or chemistry profile before treatment and at various 
times from 1 – 4 days post treatment to document any inflammatory response. 
 
Milk collection:  Samples were taken from the total milk collected from each cow after routine 
morning and evening milkings.  Blank milk samples were collected from each cow prior to 
penicillin administration.  Milk was stored at -20°C until analysis. 
 
Tissue samples:   Ten days after treatment, cows were euthanized via captive bolt gun followed 
by rapid IV potassium chloride administration.  Necropsies were performed by a pathologist at 
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the Prairie Diagnostic Services at the WCVM.  During necropsy, multiple samples of muscle, 
liver, and kidney were obtained from each cow and stored at -20°C until analysis.   
 
Drug Analysis:  Penicillin concentrations were determined in all samples by HPLC with 
ultraviolet detection at 325 nm using an adapted version of previously published protocols 
(Boison et al., 1991; Boison et al., 1992; Boison et al., 1994).   Penicillin V was used as the 
internal standard for all assays.  Calibration curves were prepared by fortifying blank plasma, 
milk, muscle, liver, and kidney samples with known concentrations of penicillin G and penicillin 
V (Sigma-Aldrich Canada Ltd, Oakville, ON, Canada).  Two hexane flushes were performed on 
milk samples to extract fat present in the milk.  Protein denaturation on all samples was 
performed with 5% sodium tungstate and 0.17 M sulfuric acid, followed by washing with 20% 
sodium chloride and vacuum filtering through a GF/B filter.  Samples were cleaned by solid 
phase extraction using Bond Elut C18 extraction cartridges (Varian Inc, Lake Forest CA, USA) 
preconditioned with methanol, water, and a 2% sodium chloride solution.  After penicillin 
extraction the cartridges were washed with the same sodium chloride solution and water.  
Penicillin was eluted with 1.0 mL elution solution (5% 0.2 M phosphate buffer / 35% water / 
60% ACN) into clean glass tubes.  1.0 mL derivitizing reagent (containing 1,2,4 Triazole and 
0.01 M HgCl2) was added to the eluent and placed in a 65°C water bath for 30 minutes.   
 An HP1100 apparatus was used, consisting of a pump system equipped with an automatic 
injector (50 – 100 μL / sample) and a UV variable-wavelength monitor at 325 nm.  Separation 
was achieved by reverse-phase column (Inertsil C8, 5 μm, 150 × 4.6 mm, GL Sciences, 
Torrance, CA, USA). The mobile phase consisted of a mixture of 28% acetonitrile and 72% 0.05 
M phosphate buffer and a flow rate of 1.2 mL/min was used.   Calibration curves were linear 
between 5 – 100, 100 – 1000, and 1000 – 10000  ng/μL for plasma, 5 – 100 and 100 – 500 ng/μL 
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for milk, and 40 – 400 ng/μL for tissues, with a coefficient of determination (r2) greater than 0.99 
for each curve.  Appendix 1 describes the complete protocol for penicillin determination in milk.  
The limits of detection and quantification (LOD and LOQ) were approximately 5 and 15 ppb 
respectively, based on measured signal:noise ratios.  The original tissue protocol was previously 
validated at the Centre for Veterinary Drug Residues (Saskatoon, SK).  
 A milk sample from each cow was qualitatively assayed for penicillin residues 
immediately following each milking using IDEXX SNAP beta-lactam test kits with visual 
inspection (90/95 level, 3.1 ppb; IDEXX Laboratories Inc., Westbrook, ME, USA).   
 
Pharmacokinetic Analysis:  Penicillin concentrations were analyzed using a commercial PK 
software program (WinNonlin, Version 2.1; Pharsight Corporation, Mountain View, CA, USA).  
A noncompartmental model was used to analyze the data.   Peak concentration in plasma (Cmax) 
and time to peak concentration (Tmax) were determined using observed values.  The apparent 
terminal rate constant, λz, was determined by linear regression of the last 7-8 points on the 
terminal phase of the logarithmic plasma concentration versus time curve.  The area under the C-
T curve until the final plasma sample (AUC0-24h) was determined using the linear trapezoidal 
rule.  The total area under the curve extrapolated to infinity (AUC0-∞) was calculated by adding 
the C24h obs/λz + AUC0-24h.  The terminal half life (T1/2λ) was calculated as ln2/λz.  Clearance 
(ClB/f) was determined by the dose divided by AUC0-∞  The apparent volume of distribution 
(Vz/f) was calculated by clearance divided by λz.  The mean residence time (MRT) was 
calculated as the area under the moment curve extrapolated to infinity (AUMC0-∞) / AUC0-∞.  
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4.4  Results 
 
Plasma penicillin kinetics:  No adverse effects were observed immediately after IP penicillin 
administration in any cow.  The log plasma penicillin concentration versus time graph is shown 
in Fig. 4.2.  The pharmacokinetic parameters for each cow are presented in Table 4.1.   The mean 
(± s.d.) Cmax and Tmax were 5.5 ± 2.6 μg/mL and 0.75 ± 0.27 h, respectively.  The mean AUC0-∞ 
was 10.8 ± 4.9 μg*h/mL.  The average MRT0-∞ and T1/2λ were 2.2 ± 0.9 h and 1.6 ± 1.0 h 
respectively.  
 
Milk penicillin residues:  Average milk production per cow over the first 5 days post-treatment 
was 8.5 ± 3.1 kg/day.  Each cow’s milk tested positive for drug residues using the SNAP ß-
lactam test kits for a minimum of three 12-h milking intervals after IP penicillin administration 
(median, 4; range, 3-5, see Table 4.2).  Quantitative milk penicillin concentrations determined by 
HPLC are shown in Fig. 4.3.  The mean ± s.d. maximum milk penicillin concentration was 222 ± 
100 ppb.  Milk residues were detectable by HPLC for at least two 12-h milking intervals 
(median, 3; range, 2-4).  
 
Tissue penicillin residues:  No penicillin residues were detected in any muscle, liver, or kidney 
samples taken at necropsy (10 d post-treatment).   
 
Safety and irritation:  Ante-mortem evidence of inflammation was determined by altered 
leukograms (neutrophilia) and decreased plasma protein/fibrinogen ratios ( ≤ 10:1 was used as 
evidence of inflammation).  Only one animal (Cow C) met these criteria at any time post-IP 
infusion.  However, a pre-treatment neutrophilia with degenerative left shit and 
protein/fibriniogen ratio of 9:1 indicated a prior inflammatory process occurring in this cow.  
Serum chemistry abnormalities included mildly elevated creatine phosphokinase and aspartate 
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aminotransferase enzymes in some cows as the trial progressed.  At necropsy, all cows had mild 
to moderate, focal hemorrhage on the greater omentum overlying the rumen (Figure 4.4).  
Peritonitis or adhesions were not observed in any animal, and no penicillin was grossly visible in 
the abdomen. 
 
 
4.5  Discussion 
 
 Data from only 8 cows were used for kinetic analysis because penicillin was not detected 
in any tissue, plasma or milk from one animal (cow A).   The absorption and elimination of 
procaine penicillin (PPG) was rapid after IP administration in 8 lactating dairy cows.  Although 
direct comparisons with historic data can be misleading, the mean time to maximum plasma 
concentration (Tmax) of 0.75 ± 0.27 h was quicker than values previously reported in the literature 
for cattle given PPG by other routes.  A Tmax of 5.3  to 6.0 h was reported for steers dosed with 
24,000 – 66,000 IU/kg PPG via IM or SC injections (Papich, Korsrud et al., 1993), compared to 
0.5 – 2.0 h after 20,000 IU/kg IM or SC injections in cows (Conlon et al., 1993).  Other studies 
reported a mean Tmax of 1.5 – 2.0 h using 30,000 IU/kg IM in calves (Bengtsson et al., 1989; 
Bengtsson et al., 1991) and 2.0 – 7.1 h after various IM doses in lactating cows (Dubreuil et al., 
2001).  A population pharmacokinetic approach estimated a Tmax of only 1.14 h after IM 
administration of procaine penicillin (Craigmill, Miller et al., 2004).   
 Intraperitoneal administration also resulted in higher maximum plasma concentrations 
(Cmax) than values obtained in other studies after IM administration with similar doses.  Mean 
Cmax after IP infusion was 5.5 μg/mL versus mean IM values of 0.99 and 1.74 μg/mL (Papich, 
Korsrud et al., 1993; Dubreuil, Daigneault et al., 2001).  The mean elimination half life (T1/2 elim) 
of PPG after IP infusion was shorter than that previously reported for IM injections (1.6 vs 7.95 
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h).  The prolonged IM half-life is due to procaine-mediated vasoconstriction which slows the 
absorption rate and thus influences elimination kinetics (Craigmill, Miller et al., 2004).  Whether 
procaine affects penicillin absorption after IP administration in cows is not clear, though an IP 
sodium ampicillin T1/2 elim reported earlier (Klein, Firth et al., 1989) was similar to the PPG T1/2 
elim in this study.  This suggests procaine does not significantly delay IP absorption.  The shorter 
Tmax after IP infusion may also be due to the large surface area for drug absorption within the 
abdomen compared to an IM injection.   
 Of interest in this study was the large inter-animal variability in Cmax (range, 1.2 – 8.8 
μg/mL).  One hypothesis is that the exact location of PPG deposition after IP infusion is not 
uniform, as drug may settle on the greater omentum, small intestines, rumen, uterus, or 
peritoneum.  Each anatomic site has its own local circulation possibly influencing the rate and 
extent of PPG absorption.  
 The question of whether intraoperative IP penicillin use in cattle is a rational therapy is 
debatable.  Overall, evidence for prophylactic antimicrobials reducing surgical infections in 
animals is mixed.  Some studies have demonstrated efficacy (Haven, Wichtel et al., 1992; 
Whittem, Johnson et al., 1999; Eugster, Schawalder et al., 2004) while others have shown no 
benefit (Vasseur, Paul et al., 1985; Brown, Conzemius et al., 1997).  The type and duration of 
surgery, surgical technique, and local conditions are important prognostic factors for the 
development of infection.  Prophylactic antimicrobial efficacy requires high plasma 
antimicrobial concentrations (including ß-lactams) at the onset of surgery, which prevents 
infection by keeping intraoperative bacterial counts below a critical threshold.  The duration of 
post-surgical therapy does not influence outcome  (Haven, Wichtel et al., 1992; Gyssens, 1999; 
Eugster, Schawalder et al., 2004; Giguere, 2006).  Therefore surgical prophylaxis guidelines 
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recommend plasma drug concentrations greater than the probable pathogen MIC before and 
throughout the surgery, but not once surgery is completed.  This is contrary to the idea of 
penicillin as a time-dependent antimicrobial when treating established infections, whereby 
maximum effect occurs when plasma concentrations remain above the pathogen MIC for a 
prolonged period (T > MIC) (McKellar, Sanchez Bruni et al., 2004).  Suitable plasma penicillin 
concentrations can be achieved at the time of surgery with preoperative IV administration, but 
this route is not commonly used by bovine veterinarians (Chicoine, 2007).  If preoperative IV 
antimicrobials cannot be administered, the goal of antimicrobial prophylaxis should be to reach 
suitable systemic drug concentrations as soon as possible after surgery has begun.  Therefore, the 
antimicrobial therapy with the quickest rate of absorption should be most effective in preventing 
post-surgical infection.  Once an infection is established however, a longer course of therapy is 
required where traditional PK/PD predictors of efficacy (such as T > MIC) will apply.   
 The rapid absorption and elimination after IP infusion of procaine penicillin create a 
plasma concentration versus time profile intermediate between those of IV and IM 
administration.  The swift absorption after IP administration predicts this route will be more 
efficacious than a single post-operative dose of IM penicillin in preventing postoperative 
infections.  However, IP administration still does not comply with the antimicrobial prophylaxis 
recommendation of plasma concentrations > MIC at the time of incision.  Therefore pre-
operative IV administration should be more effective than intraoperative IP infusion.  An 
argument made by some practitioners is that IP antimicrobials have a local effect in the 
abdomen, working directly at the site of infection.  The rapid absorption from the abdominal 
cavity refutes this theory.  If one assumes that the likely pathogens in bovine abdominal surgery 
are coliforms (especially in unsanitary surgical conditions), then penicillin should not be an 
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effective therapy due to the inherent antimicrobial resistance of coliforms.  However, Gram-
positive and anaerobic infections could be prevented by penicillin.  The pharmacokinetics of 
PPG after IP administration determined in this trial cannot be extrapolated to other 
antimicrobials or doses.  As the formulation of each drug differs, rapid absorption and 
elimination cannot be assumed and therefore IP administration of other antimicrobials cannot be 
recommended at this time.   
 Although perioperative use of IM penicillin could be argued as label therapy (for 
treatment of wound infections in cattle), IP use is definitely extralabel.  AMDUCA specifically 
states that any extralabel drug in food animals requires extended withdrawal intervals and must 
not result in violative residues.  After administration of 21,000 IU/kg PPG by IP infusion, milk 
residues were not detectable by HPLC or ELISA for any animal by 72h.  This is similar to the 
Canadian 96h milk withdrawal time after on-label IM use of the same dose.  One difference 
between the study and general populations was the low milk production of the cull cows used in 
this trial (8.5 ± 3.1 kg/cow/day).  However, low milk production correlates with reduced drug 
clearance and greater milk residues (Whittem, 1999), therefore the rapid excretion of PPG after 
IP infusion should be applicable to high producing dairy cows.  Although milk from cow C 
tested positive for ß-lactam residues using the IDEXX SNAP test, residues could not be detected 
by HPLC.  We suspect this cow’s milk had some intrinsic component that bound penicillin, as 
penicillin V internal standard added to this milk was also undetectable. 
 No penicillin residues were detected in any tissue at 10 d post-treatment.  As our small 
sample size precluded a full tissue residue depletion study, we euthanized at the label withdrawal 
time after IM administration of this same PPG dose.  The rapid decline in plasma concentrations 
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and lack of detectable tissue residues support a minimum withdrawal interval recommendation of 
10 d.   
 Although no evidence of severe gross or clinical pathological changes was noted after IP 
administration of PPG in these cows, these findings do not prove that IP infusion is safe.  The 
cause or clinical significance of the mild-moderate hemorrhage seen on the omentum is not 
known.  Although possibly an incidental finding at necropsy, the consistency of the lesion raises 
suspicion that penicillin infusion, or possibly general abdominal surgery, may be the cause. 
Cows with a previous history of abdominal surgery were excluded from the study.  
Unfortunately, in an effort to maximize the number of penicillin-treated cows, no negative or IP-
saline treated control animals were used.  Negative controls are required to specifically 
determine if abdominal surgery or IP penicillin is responsible for the hemorrhagic omentum.  
There was evidence of peritonitis in cows after IP infusions of an ampicillin anhydrate 
formulation, but not sodium ampicillin (Klein, Firth et al., 1989).  Other antimicrobials and 
formulations have not been evaluated for irritability or safety in cattle.  Although the IP route is 
generally considered non-irritating and safe in human medicine, peritoneal reactions may depend 
on the formulation of the antimicrobial.  When IP infusions are performed in people an IV 
antimicrobial formulation thoroughly diluted in a lavage/dialysis solution is used.  Other 
antimicrobials such as tetracycline, neomycin, and streptomycin can cause chemical peritonitis 
or adhesions in animals when administered IP (Withrow & Black, 1979). 
 This study found rapid absorption and elimination of PPG after IP administration of 
21,000 IU/kg in lactating dairy cows, with no evidence of prolonged meat or milk drug residues 
or serious adverse reactions.  Prospective clinical trials are required to determine if this practice 
minimizes post-surgical abdominal infections in cattle and is a rationale therapeutic choice.  
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Figure 4.1  Intraperitoneal (IP) administration of penicillin through an incision in the right 
paralumbar fossa. 
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Table 4.1  Plasma pharmacokinetic parameters determined by noncompartmental analysis 
after IP administration of 21,000 IU/kg procaine penicillin G in 8 lactating dairy cows. 
 
 
Parameter Cow B Cow C Cow D Cow E Cow F Cow G Cow H Cow I Mean ± SD 
Cmax  
(μg/mL) 3.1 1.2 3.8 5.6 8.8 7.9 7.1 6.1 
 
5.5 ± 2.6 
Tmax  
(h) 0.50 1.0 0.50 0.50 1.0 1.0 0.50 1.0 
 
0.75 ± 0.27 
λ  
(1/h) 0.53 0.45 0.49 0.52 1.11 0.18 0.51 0.52 
 
0.54 ± 0.26 
AUC0-∞ 
(μg*h/mL) 5.3 2.89 9.2 9.6 13.5 16.4 15.4 14.0 
 
10.8 ± 4.9 
AUMC0-∞  
(μg*h2/mL) 9.3 6.1 18.1 17.2 17.9 68.2 30.6 31.3 
 
24.8 ± 19.6 
MRT  
(h) 1.8 2.1 2.0 1.8 1.3 4.2 2.0 2.2 
 
2.2 ± 0.9 
T1/2 elim  
(h) 1.3 1.5 1.4 1.3 0.62 3.9 1.4 1.3 
 
1.6 ± 1.0 
ClB/f  
(mL/h/kg) 2.5 4.6 1.4 1.4 0.97 0.80 0.85 0.93 
 
1.7 ± 1.3 
Vz/f  
(L/kg) 4.7 10.2 2.9 2.6 0.87 4.5 1.7 1.8 
 
3.6 ± 2.9 
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Figure 4.2  Plasma penicillin concentration (μg/mL) vs time after IP administration of 
21,000 IU/kg procaine penicillin G in 8 lactating Holstein cows.  Bottom graph: mean (± 
s.d.) plasma penicillin concentrations vs time.  
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Table 4.2  IDEXX SNAP ß-lactam test results at each 12 h milking interval after IP 
administration of 21,000 IU/kg procaine penicillin G in 8 lactating Holstein cows. 
Milking 
Number  
Cow B Cow C Cow D Cow E Cow F Cow G Cow H Cow I 
1 + + + + + + + + 
2 + + + + + + + + 
3 + + + + + + + + 
4 - - + + + + + + 
5 - - - + + + - - 
6 - - - - - - - - 
 
 
Figure 4.3  Milk penicillin residues (ppb) vs time after IP administration of 21,000 IU/kg 
procaine penicillin G in 8 lactating Holstein cows. 
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Figure 4.4  Photograph of typical focal hemorrhage on the greater omentum overlying the 
rumen 10 days after IP infusion of 21,000 IU/kg PPG.  
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Appendix 4.1  Summary of protocol used for penicillin residue determination in bovine 
milk (developed Jan/Feb 2006, revised Mar 2007) 
 
Penicillin Extraction: 
 
1. Standard curve 100-500 ppb 
Dispense 10 mL of known “blank” milk (can use 3.25% milk fat/homogenized milk or whole 
milk) into 6 * 50 mL disposable PVDF centrifuge tubes.  Spike each sample with 200 μL of a 
20 μg/mL Pen-V working standard solution (this will give a final concentration of 400 ng/mL 
Pen V internal standard).  Add the following volumes of Pen-G using a 20 μg/mL working 
standard solution: 
 0 μL = 0 ppb 
 50 μL = 100 ppb 
 100 μL = 200 ppb 
 150 μL = 300 ppb 
 200 μL = 400 ppb 
 250 μL = 500 ppb 
  
 Vortex tubes for 10 seconds. 
 
Unknown milk samples:  All milk samples will be undiluted and contain 10 mL milk.  Spike 
each sample with 200 μL of a 20μg/mL Pen-V working standard solution to give 400 ng/mL 
Pen-V internal standard.  Vortex tubes for 10 s. 
  
2. Add 2 mL hexane to each tube.  Vortex for 10 seconds. 
 
3. Centrifuge tubes for 5 minutes at 1500 X G.  During centrifugation time, proceed to 
condition C18 SPE cartridges (step 14). 
 
4. Aspirate hexane and “solid” layer from tubes using a disposable glass pipette with 
vacuum suction. 
 
5. Add another 2 mL hexane to each tube, vortex, and centrifuge. 
 
6. Again aspirate hexane layer from tubes.  Ensure at least 5 mL “milk” remains after 
aspiration. 
 
7. Pipette 5 mL of post-hexane extraction milk into a clean 50 mL PVDF centrifuge tube.  
Discard remaining milk. 
 
8. Add 20 mL distilled water, 5 mL 5% sodium tungstate, and 5 mL 0.17 M sulfuric acid to 
the milk.  Shake by hand for 10 seconds. 
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9.  Centrifuge at 1500 X G for 10 minutes. 
 
10.  Aspirate any hexane bubbles from the top of the supernatant. 
 
11. Vacuum filter the supernatant through a 5.5 cm GF/B filter paper into a 125mL sidearm 
flask.  For successful filtration, pre-wet the filter paper with distilled water and ensure 
solution flows through centre of the filter. 
 
12.  Pour filtrate into a clean 50mL PVDF centrifuge tube.  Add 10mL of a 20% NaCl 
solution to the filtrate and vortex for 5 seconds. 
 
13.  Centrifuge at 1500 X G for 10 minutes. 
 
14.  Prepare a set of Bond-Elut C18 SPE columns with 75 mL reservoirs on the vacuum 
block.  Condition C18 SPE columns by flushing with 20mL methanol, 20mL water, and 
10mL 2% NaCl. 
 
15.  Pour supernatant into reservoir. (If C18 SPE columns are becoming clogged, an 
additional filtration step can occur here). 
 
16.  Ensure a flow rate of approx. 1 drop/sec.  Vacuum suction will likely be required, but do 
not exceed -20 mmHg.  After sample is loaded on the C18 SPE column, wash the column 
with 10mL 2% NaCl and follow with 10mL distilled water.  Continue drawing air 
through the column for a further 3 minutes. 
 
17.  Remove the reservoir and adaptor from the SPE column.  Elute the penicillins from the 
column with 500μL Elution Solution into a 10 mL glass test tube.  Vacuum suction will 
be required. 
 
18.  Add 500 μL Derivatizing Reagent to the eluate and vortex.  Place the tube in a 65°C 
heating block for 30 minutes. 
 
19.  Allow the tubes to stand for 10 minutes at room temperature.  Filter a sample aliquot 
through an Acro filter into an HPLC sample vial. 
 
20.  LC parameters: 
• Sample volume = 50 μL 
• Flow rate = 1.2mL/min 
• Detector wavelength = 325 nm 
• Run time = 10 minutes 
• Column temp = 27°C 
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Chapter 5:  Conclusions and Further Discussion 
 
 
5.1  Overall summary 
 
 The experimental results discussed in this thesis—the incidence, kinetics, milk and meat 
residues, and safety of IP penicillin use in cattle—are part of a larger central question: Is IP use 
of antimicrobials justified during bovine abdominal surgery?  Frankly, I began this investigation 
skeptical of the prophylactic or therapeutic claims attributed to IP antimicrobial use by 
veterinarians. The possible adverse effects of IP use, such as prolonged milk and meat residues 
and peritonitis, were also cause for apprehension.  We realized that justifying this practice would 
require demonstrating IP antimicrobial use was actually effective in preventing postoperative 
infections, but was beyond the scope of an MSc project.  However, other important questions 
concerning IP use remained.  Is IP administration common during bovine surgery, and if so, 
which drugs are used?  What are the plasma pharmacokinetics after IP administration, and do 
they predict efficacy?  What are reasonable meat and milk withdrawal times after IP 
antimicrobial use?  And is this practice safe for the animal?   
 The survey results presented in Chapter 3 confirm that perioperative antimicrobial use is 
nearly universal among Western Canadian bovine practitioners.  The use of IP antimicrobials is 
common during bovine abdominal surgery (more than half of the veterinarians reported using IP 
antimicrobials at least occasionally), though not as routine as postoperative IM or SC therapy.  
Procaine penicillin G was the most commonly used IP drug so it was selected for the ensuing 
pharmacokinetic and drug residue experiment.  Milk and meat withdrawal recommendations 
after IP administration were generally longer than the corresponding label intramuscular (IM) 
withdrawal time. 
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 The pharmacokinetic results described in Chapter 4 demonstrate that IP procaine 
penicillin is rapidly absorbed in lactating dairy cows, with a Tmax occurring within 0.5 – 1.0 h.  
Elimination from plasma was also rapid, as most plasma samples were below the limit of 
detection by 24 h.  The first milking after IP administration had the highest penicillin 
concentrations, with rapid declines in subsequent milkings.  Milk samples tested positive using a 
standard on-farm antimicrobial test kit for 3-5 milkings.  No penicillin residues were detected in 
any tissue 10 days after administration.  Necropsies did not reveal serious peritonitis or 
adhesions, though diffuse focal hemorrhage on the omental surface was present in most cows.  
The major finding from this study was the rapid rise and decline in plasma penicillin 
concentrations.  This result is similar to the only other study examining IP antimicrobial use in 
cattle (Klein, Firth et al., 1989), in which sodium ampicillin (but not ampicillin anhydrate) 
concentrations rapidly declined after an early peak.   
 These conclusions can be summarized as follows.  We know that extra-label IP 
antimicrobial use does occur in Western Canadian veterinary practices.  Procaine penicillin is 
rapidly absorbed and excreted after IP administration.  Milk and meat residue violations should 
not occur if the IM dose is given by IP infusion, as long as reasonable withdrawal intervals are 
followed.  The label withdrawal times after IM procaine penicillin administration (96 h for milk, 
10 d for meat) are appropriate.  Intraperitoneal procaine penicillin may cause mild abdominal 
irritation, but this is not likely clinically relevant.  Because current surgical prophylaxis 
guidelines predict antimicrobial efficacy based on plasma concentrations > MIC immediately 
before and during surgery, I predict the rapid absorption after IP procaine penicillin 
administration will result in equal to or greater efficacy than a postoperative IM dose in 
preventing post-surgical infections in cattle. 
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 Finally, these results are pertinent to the larger issue of IP antimicrobial appropriateness.  
Many of the reasons for my initial skepticism—the unknown pharmacokinetics, residue 
depletion, and safety of this practice—were refuted by the results of these trials.  This data does 
not demonstrate that IP antimicrobial use in cattle is unjustified, and it is certainly more rational 
than some other common perioperative antimicrobial practices. 
 
5.2  Relevance of this Research 
 What is the overall impact of this research on veterinarians and the broader scientific 
community?  These results are applicable to relatively few disciplines; but the conclusions are 
useful to veterinarians, pharmacokineticists, and residue chemists. 
  
5.2.1  Extra-label drug use guidelines 
 As stated in the introduction to this thesis, administering drugs by IP infusion constitutes 
extra-label drug use (ELDU).  Although an accepted part of veterinary practice in North 
America, numerous agencies have created guidelines to ensure ELDU is prudent and justified.  
IP drug use meets some of these criteria, such as performance only under the direction of a valid 
veterinarian-client relationship.  Conformity with other ELDU guidelines could not be evaluated 
because information about IP use was lacking.  Data from our experiments addresses some of 
these deficiencies.  The major thrust of ELDU regulations for food animals under both 
AMDUCA and CVMA guidelines is the avoidance of violative drug residues and risk to human 
food safety.  Previously no residue depletion data was available to create appropriate withdrawal 
recommendations, but the rapid elimination of procaine penicillin after IP infusion in our study 
allows confidence in using label IM withdrawal times.  This would satisfy Canadian ELDU 
guidelines, but AMDUCA requires another condition before ELDU is employed, that the health 
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or welfare of the animal is jeopardized and no other drug product used on label will be effective 
for this condition.  Because clinical efficacy trials were not performed, we cannot evaluate IP 
penicillin effectiveness in preventing post-surgical infections against other licensed 
antimicrobials used on-label.  However, the Center for Veterinary Medicine exerts regulatory 
discretion during enforcement; though this specific question is unresolved it does not incriminate 
IP penicillin use as imprudent.  So long as adequate withdrawal periods (which are now known) 
are followed, IP penicillin use appears to comply with guidelines regulating ELDU in North 
America. 
 
5.2.2  Preventing meat and milk penicillin residue violations  
 
 Procaine penicillin is an over-the-counter (OTC) drug that can be purchased from any 
veterinary clinic, feed store, or even pet stores without a veterinary prescription.  It is accessible, 
inexpensive, and effective and thus routinely used.  Administration of IP penicillin should only 
performed during abdominal surgery by a veterinarian, therefore constituting an exceedingly 
small proportion of the total penicillin use in cattle.  The vast majority of drug residue violations 
are a result of simply failing to follow the withdrawal time before shipping milk or meat, not 
because the withdrawal time was unknown.  Therefore, the relatively rare occurrence of IP 
penicillin use (compared to total penicillin use) is unlikely to be a significant source of penicillin 
meat or milk residue violations.  So what was the point in determining residue depletion 
kinetics?  Because IP administration is ELDU, the veterinarian is responsible for any violative 
drug residues that may be incurred when using this route, and must determine an appropriate 
withdrawal interval for the producer.  No data previously existed to predict a withdrawal interval 
with any confidence.  This meant veterinarians either had to recommend excessively 
conservative intervals (a financial burden especially for dairy farmers), or risk a residue violation 
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with shorter times.  Knowledge of IP penicillin milk and meat residue depletion may not make 
the food supply much safer, but it will reduce unnecessary milk discard and keep a few 
veterinarians from regulatory action. 
 
5.2.3  Relevance to bovine surgery 
 
 Information derived from this IP project is not likely to significantly alter the 
perioperative antimicrobial use of bovine veterinarians.  Those who already believe IP 
antimicrobial administration is beneficial can examine our data and can reasonably make the 
following conclusions: 
• penicillin is quickly absorbed and high plasma concentrations are attained, and is  
 
therefore likely to be an effective perioperative treatment  
 
• milk and meat residue depletion is rapid, so residue violations are unlikely 
 
• IP administration is safe and non-irritating for the cow 
 
Conversely, others who view this practice as irrational can rebut that efficacy data is still lacking 
after IP antimicrobial use, therefore it cannot be justified over conventional routes of 
administration.  If clinical efficacy studies were performed that demonstrated a reduction in post-
surgical infection rates in IP-penicillin treated cows compared to other groups, this practice may 
become more widely accepted.  On the other hand, if our results showed a clear risk of serious 
adverse effects such as peritoneal inflammation or fibrin deposits, or extended milk and meat 
residues, the practice of IP administration would be discredited.  Neither scenario occurred so it 
is unlikely this study will produce major changes in current IP antimicrobial practices.   
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5.3  Limitations of study data 
 
 The experimental data was overall quite useful, but of course in retrospect some aspects 
of experimental design and implementation were not optimal.  Certain limitations were known a 
priori but could not be corrected due to financial or logistical constraints.  Other limitations were 
only uncovered after post hoc analysis.  The following discussion elaborates on limitations 
presented in the earlier chapters before describing future areas of research. 
 
5.3.1  Survey data limitations 
 
 WCABP members were surveyed as we felt this group was representative of bovine 
practitioners across Western Canada and a central mailing list was easily accessible.  The survey 
response rate (98/240, or 40.8%) was satisfactory. As there are approximately 885 mixed or large 
animal veterinarians in Western Canada (Jelinski, 2006), the 98 responses represent more than 
10% of all bovine veterinarians so conclusions can be safely drawn from this sample size.  
However, because all respondents are from Western Canada the results cannot be generalized 
across Canada or North America.  Specifically, the regular use of IP administration may only be 
a regional phenomenon.  This is certainly feasible; many Western Canadian veterinarians were 
trained at the same institution (WCVM) by the same professors.  Anecdotally, some 
veterinarians reported learning of IP neomycin use from WCVM faculty.  As well, many 
veterinarians are mentored by more experienced practitioners and certain techniques (such as IP 
administration) could easily be “passed down the veterinary generations” within a specific 
region.  Unfortunately, resources were not available to survey bovine veterinarians in other 
regions. 
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 Bias was present in the survey design.  Because surveys were anonymous, follow up was 
not available.  No ethics approval was obtained for this survey, and some veterinarians may not 
have responded without knowing how the data was to be used.  Practitioners who do not 
routinely use perioperative antimicrobials simply may have not responded, skewing the results 
towards those who use antimicrobials.  Personal information such as graduation year or practice 
location was not asked to keep responses confidential.  Without this data, we cannot determine if 
respondents were clustered by age (experience) or geography.     
 Survey interpretation was complicated by the rather informal survey design (see Figure 
3.1 for the survey design). Further proofreading and editing may have clarified the questions.  
Some responses listed multiple antimicrobials commonly used at each surgical time frame (there 
were 3 lines available), but what percentage of cows were treated with each drug was not asked.   
Likewise, percentage of cows treated at each surgical time frame was estimated and true 
occurrence cannot be determined.  Withdrawal recommendations after pre- or postoperative 
administration were not solicited; we assumed that veterinarians would recommend label 
withdrawal times but this assumption may not be correct.  Finally, errors were possible when 
categorizing multiple drug trade names and formulations together.  For example, a practitioner 
who responded “oxytetracycline” (OTC) may have meant a short-acting (OTC HCl) or long-
acting (OTC in polyethylene glycol) product, or some combination.   
 
5.3.2  Pharmacokinetic and residue experimental design limitations 
 
Animal selection:  All cows used in this trial were cull dairy cows.  The cows were in relatively 
good health, were free of mastitis, ate and drank well, and were normal on physical exam.  
Abnormalities included lameness (Cow B) and an inflammatory leukogram (Cow C).  Milk 
production was generally much lower than expected on a commercial dairy, 8.5 ± 3.1 
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kg/cow/day in this trial versus approximately 30 kg/cow/day.  This difference makes 
extrapolation of milk drug excretion rates to other dairy cows suspect.  However, low milk 
production correlates with lower drug clearance and prolonged milk residues (Whittem, 1999), 
therefore the rapid penicillin excretion after IP infusion should also be applicable to high 
producing dairy cows. 
 
Analytical methodology:  The protocols used in this experiment were derived from the CFIA’s 
validated tissue penicillin residue protocol and adapted for plasma and milk matrices.  
Unfortunately, method validation was beyond the scope of this project.  Method validation is 
required to have full confidence in the numbers generated for either plasma or milk.  The 
accuracy and recovery of the methods were not determined, neither was the precision.  Limit of 
detection (LOD) and limit of quantification (LOQ) were estimated from the standard curves 
based on signal:noise ratios but a quantitative approach using deviation of standard curve y-
intercepts would be more precise.  The HP1100 HPLC apparatus used in the WCVM lab 
produced consistent results, especially after the initial phase of the trial when sample preparation 
difficulties were resolved.  Analysis of earlier samples (cows B and C) was more problematic.  
Likewise, samples should have been stored at -70°C (not -20°C) as penicillin degradation likely 
occurred at the higher temperature.  This is suspected because samples from cows B and C were 
re-analyzed 8 months after initial tests; penicillin concentrations were roughly half the original 
values.  Penicillin residues in milk from Cow C could not be determined, as no Pen G (or Pen V 
internal standard) peaks were detectable on the chromatogram.  This occurred despite multiple 
analyses at both CVDR and WCVM labs.  I suspect some component of this particular cow’s 
milk (such as increased milk fat, protein, or somatic cell count) bound penicillin molecules; 
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therefore any penicillin in the milk was lost along with these components during sample 
preparation. 
   
Plasma penicillin concentrations: The plasma PK experimental design worked very well overall.  
Knowing now the rapid IP absorption, I would incorporate extra blood samples at 0.75 and 1.5 h 
to further clarify the Tmax and Cmax.   Comparisons to plasma PK parameters obtained in other 
studies were made in Chapter 4, but these comparisons may not be valid for a number of reasons. 
The study populations will not be identical.  For example, penicillin clearance in steers may not 
be the same as in lactating dairy cows because steers do not have drug excretion into milk.  
Differences in housing, feed, and seasonal conditions between studies should not influence 
penicillin disposition but this is not known conclusively.  Values obtained using one analytical 
method cannot be assumed equal to values obtained from other assays, as systemic bias between 
methods may account for differences.      
 
Milk penicillin residues: A 12h milk sampling schedule was chosen to mimic typical dairy 
milking frequencies.  However, because the milk penicillin residues were not detectable after 
only 3-5 milkings the milk residue depletion curve consisted of few data points.  Taking more 
frequent milk samples (every 6 hours, for example) would create more data for the residue 
depletion curves.  The problem with this approach is that it does not represent what happens on 
farm.  If cows are milked every 12 hours, the penicillin concentration in milk will reflect 
excretion over that entire period.  Milk produced earlier in the 12 h interval with high penicillin 
concentrations will be diluted by lower penicillin concentrations in milk produced later.  The rate 
of milk production may also change over the milking interval, thus altering the penicillin 
concentrations.  Milk penicillin concentrations from two 6 h intervals cannot be averaged to 
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predict a 12 h interval concentration.  Using the IDEXX SNAP ß-lactam rapid test kits on 
individual milk samples allowed early yes-or-no impressions of milk residues.  However, this 
qualitative analysis was performed visually and milk samples taken 48 – 60 h after penicillin 
infusion were difficult to assess.  Investment in a semi-quantitative sample reader would provide 
objective results, but the test kits are only certified for use on bulk tank milk so individual cow 
milk results produced by the sample reader may not be accurate either.     
 
Tissue penicillin residues: Tissue residue depletion curves could not be constructed from our 
data, as all muscle, kidney, and liver samples taken 10 days after penicillin administration were 
below the limit of detection of the HPLC assay (LOD = 2 ppb, MRL = 50 ppb).  One proposal 
was to euthanize each batch of 3 cows at different intervals, such as 4, 7, and 10 days post-
administration.  This may have resulted in detectable penicillin residues, and possibly a residue 
depletion curve.  There were two problems with this approach, however.  The first is that only 3 
data samples would be available at each time point, which does not give a good estimate of 
variability.  The second problem is that the residue depletion curve would consist of a maximum 
of 3 points, and possibly only one or two if the depletion was rapid.  Because the project budget 
was limited to nine cows, increasing the sample size was not an option.  One suggestion was to 
obtain muscle biopsies from each cow at multiple time points after drug administration to create 
a muscle residue depletion curve.  This was not feasible as 5 g of muscle tissue is required for 
each assay (too large for a normal biopsy), local anesthetic infusion required for biopsy may 
interfere with the chromatogram, and superficial muscle samples from one region are not 
acceptable for CFIA residue analysis.  We decided instead to euthanize all cows at 10 days post-
infusion because this is the label withdrawal time after intramuscular administration of the same 
penicillin dose.  Constructing a residue depletion curve would be helpful but not vital; the ability 
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to recommend a withdrawal interval with confidence was more important.  Because the 
CgFARAD’s policy is not to recommend a withdrawal interval shorter than the label withdrawal 
time, it is unlikely that withdrawal interval less than 10 days would be recommended anyways.  
It was more important that all tissue residues be below the MRL at this time point.   
 
IP irritability/safety:  Overall, IP procaine penicillin did not result in peritoneal inflammation or 
irritability.  The blood chemistry results showed no evidence of inflammation, other than one 
cow with a pre-existing inflammatory process.  Lesions described in previous studies (Klein, 
Firth et al., 1989) such as fibrin deposits and peritonitis were not observed.  Significance of the 
consistent focal omental hemorrhages seen at necropsy cannot be determined, however.  Were 
they a result of chemical irritation due to penicillin, a normal response to abdominal surgery, or 
an incidental finding in old cows?  The design of this trial did not allow for statistical evaluation 
of IP penicillin irritability.  A control group of IP saline-infused cows was considered, but would 
have required doubling the number of cows which was cost prohibitive.  The other option was to 
divide the nine cows into penicillin and saline treated groups, but this would produce less 
penicillin data (the rationale behind the entire study).  A crossover trial was also considered, 
whereby half the cows would receive IP penicillin and half IP saline.  After a washout period of 
two or three weeks the treatments would be switched and the cows euthanized.  If differences 
were noted between groups at necropsy (such as IP penicillin cows having focal omental 
hemorrhage, but not saline cows) then the statistical likelihood of differences between groups 
could be assessed.  However, with such a small sample size and non-parametric results (necropsy 
score or area of hemorrhage) it would be difficult to find a statistically significant difference.  
Conversely, if both groups (penicillin and saline) had the same lesions at necropsy, the safety of 
IP penicillin would not be proven.  Perhaps the hemorrhage in the IP saline group was due to the 
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previous cycle’s IP penicillin administration (not the IP saline) and did not resolve after the 
washout period.  In either case, determining if IP penicillin causes abdominal lesions would 
require a larger number of control animals than was feasible here. 
 
 
5.4  Areas for Future Intraperitoneal Drug Research  
 
  
5.4.1  Evaluation of clinical efficacy  
 
 Various investigations designed to assess the efficacy of perioperative antimicrobials in 
preventing or treating post-surgical infections are possible.  One difficulty common to all 
investigations is that the generic endpoint “post-surgical infection” is a subjective definition.  
Surgical site (incision) infections, intra-abdominal inflammation/abscesses, or animals with high 
temperature or poor performance after surgery may all be classified as “post-surgical infections”.  
Establishing an objective definition for post-surgical infections is essential.  The gold standard 
test would be a positive bacterial culture from the infected area.  This is feasible for incision site 
infections, but not when the infection is intra-abdominal.  Ultrasound could be employed to 
diagnose abdominal abscesses, though bacterial culture from the abscess may not be possible.  
Even a positive bacteria culture does not confirm an “infection” per se as the bacteria may not be 
pathogenic but part of the normal flora.  Any classification scheme would have to incorporate a 
number of observations, such as clinical findings (elevated rectal temperature, depression score, 
decreased appetite or milk production) and laboratory results (neutrophils/bacteria on cytology or 
complete blood count, decreased fibrinogen:total solids ratio).   
 
Retrospective cohort study:  Examining the WCVM large animal clinic hospital records may 
provide the information necessary to determine the incidence of post-surgical bovine infections.  
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Intraperitoneal antimicrobial use is not routine at the WCVM however, so no data is available on 
infection rates after IP administration.  In veterinary clinics that routinely use IP antimicrobials, 
lack of detailed records on post-surgical infections makes comparisons between cases difficult.  
Even if this information was available, retrospective studies cannot prove cause-and-effect.  A 
correlation may be found between IP antimicrobial use and rates of post-surgical infections, but 
due to the multitude of confounding factors causality cannot be established.  
 
Experimental abdominal infection model:  In this experiment, cows would receive an IP 
inoculum of a known quantity of bacteria to mimic contamination during abdominal surgery.  
Presence of infection would be determined at various time points after inoculation.  One group of 
cows would receive no antimicrobials (negative control), one would receive intraoperative IP 
antimicrobials, and other groups would be positive controls (such as preoperative IV or 
postoperative IM antimicrobials).   However, the specific pathogens hypothesized to cause post-
surgical infections are not conclusively defined in cattle.  Even if known, IP challenge with 
pathogenic bacteria does not mimic real-life conditions.  Surgical infections may arise due to 
traumatic tissue handling and local necrosis, or polybacterial infection (such as fecal 
contamination).  It would be difficult to mimic real-life operating conditions while maintaining a 
consistent bacterial challenge between animals.  As well, because most animals undergoing 
simple abdominal surgery do not become infected (Klein & Firth, 1988; Haven, Wichtel et al., 
1992; Desrochers, 2005), the sample size needed to establish significant differences between 
groups becomes prohibitive. 
 
Prospective randomized clinical trial:  As the number of bovine abdominal surgeries performed 
at the WCVM is limited, private bovine practitioners and their clients could be enlisted in a 
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prospective clinical trial to determine post-surgical infections during “normal” bovine abdominal 
surgery.  This is extremely difficult for a number of reasons.  Besides the problem with 
establishing a common definition of post-surgical infections (especially among multiple 
veterinarians and producers), no two surgeries are identical.  Even among routine abdominal 
surgeries such as caesarian sections, some are performed quickly and easily while others are 
lengthy and difficult.  The degree of abdominal contamination can vary drastically, especially if 
the cow becomes recumbent during surgery or some other breach in sterility occurs.  Surgical 
skill varies between veterinarians, so between-surgeon rates of infection could confound the 
results.  Although each animal undergoing abdominal surgery could be randomized into various 
treatment groups before surgery (perhaps by rolling a dice before each surgery), it would be 
impossible to blind the surgeons as to which treatment group the cow was in.  Bias is therefore 
inevitable.  Veterinarians may be more careful when performing surgery if knowing the cow will 
be a negative control with no antimicrobials, or careless if antimicrobials are administered.  The 
veterinarian and producer must also agree to follow the randomization scheme and not treat the 
animal empirically. 
 It would certainly be difficult to define objective outcome assessments (post-surgical 
infection) and properly control bias in this trial.  However, once these challenges are resolved the 
experimental results would unequivocally answer if IP antimicrobial use reduces post-surgical 
infections.  Another benefit would be a current, accurate assessment of post-surgical infection 
rates and possible etiologies (if culture results are obtained).  I hypothesize that animals treated 
with IP antimicrobials would have post-surgical infection rates no lower (and likely higher) than 
cows with preoperative IV treatment but lower than negative controls.  IP use would therefore 
not be justified if a better alternative (preoperative IV treatment) exists.  However, this is only a 
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hypothesis at this time.  Other questions to answer:  would intraoperative IP antimicrobials result 
in fewer infections than postoperative IM treatment?  Would all treatment groups have infection 
rates lower than the negative control group?  Are there differences between infection rates for 
treatment groups depending on co-variables such as the type of surgical procedure or location of 
surgery?   
 Unfortunately, with 4 treatment groups (negative control, intraoperative IP, preoperative 
IV, and postoperative IM), co-variables (surgeon, surgical procedure, location of surgery, etc.), 
and relatively low post-surgical infection rates, a large sample size would be required.   
Assuming a relatively high post-surgical infection rate of 15% in the negative control group (de 
Kruif, van den Brand et al., 1987; Seger, Grunert et al., 1994; Desrochers, St-Jean et al., 1996; 
Bedard, Desrochers et al., 2001; Desrochers, 2005), and a 5% infection rate in treated animals (a 
67% reduction), each group would need 159 animals for the study to demonstrate a significant 
difference with 95% confidence (two-tailed) and 80% power (Browner, 2001).  That requires 
enlisting at least 636 separate surgeries in the trial, a difficult (though not impossible) number. 
 
5.4.2  Further survey data 
  
 Is IP antimicrobial use only a Western Canadian phenomenon?  Surveys of other 
jurisdictions in North America could answer this question.  Specifically, the American 
Association of Bovine Practitioners (AABP) would provide an excellent base of large animal 
veterinarians.  I suspect IP antimicrobial use does occur in other jurisdictions, based on anecdotal 
evidence from the AABP listserve.  A survey of AABP members would be feasible; links to 
other electronic surveys have been posted on their listserve.  An electronic survey might allow 
for follow up with respondents and non-respondents, which was not possible with the previous 
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survey.  As for refining the survey questions, I would keep the same general design but include 
more detail.   
• Asking respondents to write the percentages of abdominal surgeries they treat with 
specific antimicrobials may give more accurate data.  For example, “What percentage of 
abdominal surgeries receive preoperative:” 
 Procaine Penicillin  _____ 
 Oxytetracycline LP  _____ 
 Ceftiofur   _____ 
 Other, etc.    _____   
This question would be repeated for postoperative and IP use.  Listing multiple 
antimicrobials ensures seldom-used antimicrobials won’t be overlooked by the 
respondent. 
 
• Questions regarding frequency of IP antimicrobial use should include a breakdown for 
specific surgeries, in case some veterinarians use the IP route for some surgeries but not 
others.  For example, perhaps some practitioners treat all ceasarian sections with IP 
antimicrobials due to possible contamination from the uterus, but not displaced 
abomasums or umbilical hernias. 
 
• After asking for recommended meat and milk withdrawal information, ask how these 
values were determined.  Did the practitioner contact FARAD, find kinetic data on 
his/her own to base a withdrawal interval, simply extend the label time, or just make up a 
number? 
 
• Because the survey would be electronic and completely confidential, personal 
information could be requested.  Variables such as “# years in practice” and “geographic 
location” could be analyzed to look for significant differences in perioperative 
antimicrobial use.   
 
 
5.4.3  Refining analytical methods to detect penicillin 
 
 Before pursuing further experiments requiring penicillin analysis of plasma, milk, or any 
other non-tissue matrix, validation of the HPLC penicillin assay is required.  Method validation 
can be time-consuming and difficult, and was not deemed necessary due to the limited scope and 
“pilot project” nature of this thesis.  Although our plasma and milk concentrations cannot be 
accepted with full confidence, they are valid as initial estimates.  However, any additional 
88 
 
projects analyzing larger sample numbers require greater confidence in the data produced, thus 
method validation is mandatory. 
 
5.4.4  Kinetic differences between IP and other routes of administration 
 
 If the concept that clinical efficacy of an antimicrobial can be predicted based on its 
PK/PD parameters (such as Cmax, Tmax, AUC, or T>MIC) is accepted, then the relative efficacies 
of different routes of administration for the same antimicrobial can also be predicted.  It must be 
noted that the predictive value of these PK/PD parameters has not been conclusively determined 
for perioperative antimicrobial drug use.  PK/PD parameters for each route of administration can 
be obtained using a simple crossover trial.  For example, 9 cows would be divided into three 
groups, each group receiving procaine penicillin by a different route (such as IM, SC, and IP).  
Blood would be collected as per the sampling schedule in this trial.  After an appropriate 
washout period (14 days), the cows would be treated again but with a different route until each 
group receives penicillin by all three routes.  In this manner each cow serves as her own control, 
thus increasing the power of the trial to detect significant differences in plasma kinetics. 
 
5.4.5  Complete milk and meat residue depletion studies 
 
 As addressed in the study limitations, full meat and milk penicillin residue depletion trials 
were not performed after IP infusion.  Although this information would be interesting, it is not 
vital—our data demonstrates that the label meat and milk withdrawal times for IM 
administration should be adequate. Full residue depletion data is required if a company wishes to 
pursue a product label claim for IP administration, but this is highly unlikely as the target market 
for this procedure (veterinarians performing abdominal surgery) is too small to support the 
financial expenditure required. 
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5.4.6  Extended irritability/safety studies 
 
 Although our trial did not demonstrate peritoneal irritation or systemic adverse effects 
after IP procaine penicillin administration, it could not conclusively prove the safety of this 
practice.  As discussed earlier, proof of safety requires a prospective study using a negative 
control group (with IP infusions of saline).  Frankly this information seems unnecessary.  The 
cows in our trial did not exhibit any signs of peritonitis or inflammation and had normal 
leukograms.  One could argue that the low milk production was due to abdominal discomfort and 
decreased appetite, but I would argue that the low production was due to old, cull cows 
transported to a new facility and eating a new ration.   
 
5.4.7  Kinetics and residues of other IP antimicrobials 
 
 The survey results indicate that many other drugs other than procaine penicillin G are 
administered IP during bovine abdominal surgery.  When reporting results of the kinetics and 
residue trial to veterinarians, we caution against extrapolating these results to other 
antimicrobials or penicillin formulations administered by IP infusion.  Specifically, it must not 
be assumed that other drugs (such as oxytetracycline, neomycin, ceftiofur, etc.) or formulations 
(benzathine penicillin) will be rapidly absorbed and excreted after IP use.  Nor can the residue 
depletion conclusions of this trial be applied to other drugs.  Although IM procaine penicillin 
meat and milk withdrawal times can safely be recommended after IP administration, the IM label 
withdrawal time may not apply for IP administration of other drugs (especially if the formulation 
is irritating and absorption is delayed).  Finally, despite concluding that IP procaine penicillin in 
cattle is not unsafe does not mean this conclusion is universally appropriate.  I suspect cows will 
react similarly to IP administration of other antimicrobials as they do to procaine penicillin (so 
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long as the drug formulations are non-irritating), but the only way to verify this hypothesis is if 
similar data is produced for these products.  Because procaine penicillin was the most commonly 
used IP antimicrobial in the survey it seemed rational to use it for our kinetic trials.  Similar 
experiments using oxytetracycline (the 2nd most commonly used IP antimicrobial) may be 
warranted.  Unless new data indicates a pressing need to evaluate IP use of other drugs, I would 
limit work to penicillin and oxytetracycline.  The IP use of other antimicrobials was either too 
infrequent (eg. ceftiofur, trimethorpim-sulfa), or too inappropriate (eg. neomycin) to warrant 
further investigation at this time. 
 
5.4.8  IP absorption studies 
 
 Although we determined the kinetics of procaine penicillin absorption after IP 
administration, the anatomic considerations of injecting drugs into the abdomen are not fully 
understood.  Is the liquid absorbed by blood vessels on visceral surfaces or within the omentum, 
or by peritoneal vessels on the ventral abdominal wall?  This question is not of terrible 
importance for injecting penicillin into cows, but is relevant for other species where IP 
administration is more common, such as rodents.  Drugs absorbed by peritoneal vessels are 
transported directly to the heart and then to the systemic circulation, whereas drugs absorbed by 
the splanchnic circulation may undergo extensive first pass metabolism in the liver.  Experiments 
could be devised to assess the exact locations of IP absorption and circulation.  Animals could 
receive IP injections containing a dye such as India ink and euthanized at various time points to 
determine the exact ink location.  A more suitable experiment would use IP injections of a radio-
labeled drug.  Serial imaging using nuclear scintigraphy would reveal the location of the 
compound, both within the abdomen and after absorption into the bloodstream.  The logistics of 
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this project would need to be addressed, such as the proper concentration of radio-labeled drug 
required and the necessary image timing and frequency. 
 
 
92 
 
References 
 
Ablan, C.J., Olen, R.N., Dobrin, P.B., O'Keefe, P., Tatarowicz, W. & Freeark, R.J. (1991). 
Efficacy of intraperitoneal antibiotics in the treatment of severe fecal peritonitis. 
American Journal of Surgery, 162, 453-456. 
Althaus, R.L., Torres, A., Montero, A., Balasch, S. & Molina, M.P. (2003). Detection limits of 
antimicrobials in ewe milk by delvotest photometric measurements. J Dairy Sci, 86(2), 
457-463. 
Andrew, S.M. (2000). Effect of fat and protein content of milk from individual cows on the 
specificity rates of antibiotic residue screening tests. J Dairy Sci, 83(12), 2992-2997. 
Andrew, S.M. (2001). Effect of composition of colostrum and transition milk from Holstein 
heifers on specificity rates of antibiotic residue tests. J Dairy Sci, 84(1), 100-106. 
Arthur, R.R., Drew, R.H. & Perfect, J.R. (2004). Novel modes of antifungal drug administration. 
Expert Opin Investig Drugs, 13(8), 903-932. 
Baynes, R.E., Martin-Jimenez, T., Craigmill, A.L. & Riviere, J.E. (1999). Estimating provisional 
acceptable residues for extralabel drug use in livestock. Regul Toxicol Pharmacol, 29(3), 
287-299. 
Bedard, S., Desrochers, A., Fecteau, G. & Higgins, R. (2001). [Comparison of four protocols for 
preoperative preparation in cattle]. Can Vet J, 42(3), 199-203. 
Benet, L.Z., Mitchell, J.R., Sheiner, L.B. (1990). Drug Absorption, Bioavailability, and Routes of 
Administraiton. In Drug Absorption, Bioavailability, and Routes of Administraiton Ed 
Goodman Gilman, A., Rall, T.W., Nies, A.S., Taylor, P. pp. 3-32. McGraw-Hill Inc., 
Toronto. 
Bengtsson, B., Franklin, A., Jacobsson, S., Luthman, J. & Horn af Rantzien, M. (1991). 
Distribution of penicillin-G and spiramycin to tissue cages and subcutaneous tissue fluid 
in calves. Res Vet Sci, 50(3), 301-307. 
Bengtsson, B., Franklin, A., Luthman, J. & Jacobsson, S.O. (1989). Concentrations of 
sulphadimidine, oxytetracycline and penicillin G in serum, synovial fluid and tissue cage 
fluid after parenteral administration to calves. J Vet Pharmacol Ther, 12(1), 37-45. 
Boison, J.O., Keng, L.J. & MacNeil, J.D. (1994). Analysis of penicillin G in milk by liquid 
chromatography. J AOAC Int, 77(3), 565-570. 
Boison, J.O., Korsrud, G.O., MacNeil, J.D., Keng, L. & Papich, M. (1992). Determination of 
penicillin G in bovine plasma by high-performance liquid chromatography after pre-
column derivatization. J Chromatogr, 576(2), 315-320. 
Boison, J.O., Salisbury, C.D., Chan, W. & MacNeil, J.D. (1991). Determination of penicillin G 
residues in edible animal tissues by liquid chromatography. J Assoc Off Anal Chem, 
74(3), 497-501. 
Bondar, V.M., Rago, C., Cottone, F.J., Wilkerson, D.K. & Riggs, J. (2000). Chlorhexidine 
lavage in the treatment of experimental intra-abdominal infection. Arch Surg, 135(3), 
309-314. 
Bratzler, D.W. & Houck, P.M. (2005). Antimicrobial prophylaxis for surgery: an advisory 
statement from the National Surgical Infection Prevention Project. Am J Surg, 189(4), 
395-404. 
93 
 
Brown, D.C., Conzemius, M.G., Shofer, F. & Swann, H. (1997). Epidemiologic evaluation of 
postoperative wound infections in dogs and cats. J Am Vet Med Assoc, 210(9), 1302-
1306. 
Browner, W.S., Newman, T.B., Cummings, S.R., Hulley, S.B. (2001). Estimating Sample SIze 
and Power: The Nitty-gritty. In Estimating Sample SIze and Power: The Nitty-gritty Ed 
Hulley, S.B., Cummings, S.R., Browner, W.S., Grady, D., Hearst, N., Newman, T.B. p 
88. Lippincott Williams & Wilkins, Philadelphia. 
Brumbaugh, G.W. (1990). Perioperative antimicrobial considerations for gastrointestinal surgery 
of cattle. Vet Clin North Am Food Anim Pract, 6(2), 307-333. 
Bruno, D.W. (1989). An investigation into oxytetracycline residues in Atlantic salmon, Salmo 
salar L. J. of Fish Diseases, 12, 77-86. 
CFIA (2004). Report On Pesticides, Agricultural Chemicals, Veterinary Drugs, Environmental 
Pollutants and Other Impurities in Agri-Food Commodities of Animal Origin (Dairy 
Products). In Report On Pesticides, Agricultural Chemicals, Veterinary Drugs, 
Environmental Pollutants and Other Impurities in Agri-Food Commodities of Animal 
Origin (Dairy Products). http://www.inspection.gc.ca/english/fssa/microchem/resid/2004-
2005/anima_dle.shtml. 
CFIA (2006). Report On Pesticides, Agricultural Chemicals, Veterinary Drugs, Environmental 
Pollutants and Other Impurities in Agri-Food Commodities of Animal Origin:  Meat 
Products. In Report On Pesticides, Agricultural Chemicals, Veterinary Drugs, 
Environmental Pollutants and Other Impurities in Agri-Food Commodities of Animal 
Origin:  Meat Products. Canadian Food Inspection Agency. 
Chicoine, A.L., Dowling, P.M., Boison, J.O., Parker, S. (2007). unpublished data. 
Conlon, P.D., Butler, D.G., Burger, J.P. & Gervais, M.D. (1993). Evaluation of route and 
frequency of administration of three antimicrobial drugs in cattle. Can Vet J, 34(10), 606-
610. 
Craigmill, A.L., Miller, G.R., Gehring, R., Pierce, A.N. & Riviere, J.E. (2004). Meta-analysis of 
pharmacokinetic data of veterinary drugs using the Food Animal Residue Avoidance 
Databank: oxytetracycline and procaine penicillin G. J Vet Pharmacol Ther, 27(5), 343-
353. 
CVM (1996). Milk monitoring with antimicrobial drug screening tests. In Milk monitoring with 
antimicrobial drug screening tests. Food and Drug Administration. 
CVM (2002). 21 CFR 530: Extralabel Drug Use in Animals. In 21 CFR 530: Extralabel Drug 
Use in Animals. Food and Drug Administration. 
CVMA (2002). Extra-Label Drug Use (ELDU) Position Statement. In Extra-Label Drug Use 
(ELDU) Position Statement. 
CVP (2005). Compendium of Veterinary Products, 8th US Edition. North American 
Compendiums, Ltd., Port Huron, MI. 
CVP (2005). Compendium of Veterinary Products, 9th Canadian Ed. North American 
Compendiums, Ltd., Hensall, ON. 
Dayan, A.D. (1993). Allergy to antimicrobial residues in food: assessment of the risk to man. Vet 
Microbiol, 35(3-4), 213-226. 
de Kruif, A., van den Brand, L.P., van Kuyk, M.M., Raymakers, R.J., Sietsma, C. & Westerbeek, 
A.J. (1987). [Wound healing and wound irrigation in cesarean section of cattle]. Tijdschr 
Diergeneeskd, 112(17), 990-993. 
94 
 
Desrochers, A. (2005). General principles of surgery applied to cattle. Vet Clin North Am Food 
Anim Pract, 21(1), 1-17. 
Desrochers, A., St-Jean, G., Anderson, D.E., Rogers, D.P. & Chengappa, M.M. (1996). 
Comparative evaluation of two surgical scrub preparations in cattle. Vet Surg, 25(4), 336-
341. 
Dewdney, J.M., Maes, L., Raynaud, J.P., Blanc, F., Scheid, J.P., Jackson, T., Lens, S. & 
Verschueren, C. (1991). Risk assessment of antibiotic residues of beta-lactams and 
macrolides in food products with regard to their immuno-allergic potential. Food Chem 
Toxicol, 29(7), 477-483. 
Dowling, P. (2006). Miscellaneous Antimicobials: Ionophores, Nutrofurans, Nitroimidazoles, 
Rifamycins, Oxazolidinones, and Others. In Miscellaneous Antimicobials: Ionophores, 
Nutrofurans, Nitroimidazoles, Rifamycins, Oxazolidinones, and Others Ed Giguere, S., 
Prescott, J.F., Baggot, J.D., Walker, R.D., Dowling, P.M. pp. 285-300. Blackwell 
Publishing, Ames, IA. 
Dubreuil, P., Daigneault, J., Couture, Y., Guay, P. & Landry, D. (2001). Penicillin 
concentrations in serum, milk, and urine following intramuscular and subcutaneous 
administration of increasing doses of procaine penicillin G in lactating dairy cows. Can J 
Vet Res, 65(3), 173-180. 
Ericsson, C.D., Jr., D.J.H. & Pickering, L.K. (1978). Clinical pharmacology of intravenous and 
intraperitoneal aminoglycoside antibiotics in the prevention of wound infections. Ann 
Surg., 188(1), 66-70. 
Eugster, S., Schawalder, P., Gaschen, F. & Boerlin, P. (2004). A prospective study of 
postoperative surgical site infections in dogs and cats. Vet Surg, 33(5), 542-550. 
Fairgrieve, W.T., Masada, C.L., Peterson, M.E., McAuley, W.C., McDowell, G.C. & Strom, 
M.S. (2006). Concentrations of erythromycin and azithromycin in mature Chinook 
salmon Oncorhynchus tshawytscha after intraperitoneal injection, and in their progeny. 
Dis. Aquat. Organ., 68(3), 227-234. 
FDA (1994). Guideline for establishing a withdrawal period. In Guideline for establishing a 
withdrawal period. US Food and Drug Administration. 
FDA (2004). Section 6, Grade "A" Pasteurized Milk Ordinance (2003 Revision). In Section 6, 
Grade "A" Pasteurized Milk Ordinance (2003 Revision). 
Fensterbank, R. (1976). Oxytetracycline treatment of cows with long-standing brucellosis. Ann. 
Rech. Vet., 7(3), 231-240. 
Fry, D.E., Trachtenberg, L. & Polk, H.J. (1986). Serum kinetics of intraperitoneal moxalactam. 
Arch. Surg., 121(3), 282-284. 
Gauchia, R., Rodriguez-Serna, M., Silvestre, J.F., Linana, J.J. & Aliaga, A. (1996). Allergic 
contact dermatitis from streptomycin in a cattle breede. Contact Dermatitis, 35(6), 374-
375. 
Gibbons, S.N., Kaneene, J.B. & Lloyd, J.W. (1996). Patterns of chemical residues detected in US 
beef carcasses between 1991 and 1993. J Am Vet Med Assoc, 209(3), 589-593. 
Giguere, S., Walker, R.D. (2006). Antimicrobial prophylaxis for surgery. In Antimicrobial 
prophylaxis for surgery Ed Giguere, S., Prescott, J.F., Baggot, J.D., Walker, R.D., 
Dowling, P.M. pp. 340-344. Blackwell Publishing, Ames, Iowa. 
Gitzel, A. & Grunder, H.D. (1994). The evaluation of the administration of Totocillin suspension 
in bovine surgery and postoperative prophylaxis. Tierarztliche-Umschau., 49(5), 295-
298. 
95 
 
Gummow, B., Botha, C.J. & Williams, M.C. (2006). Chronic vanadium poisoning in calves and 
its treatment with calcium disodium ethylenediaminetetraacetate. Vet Res Commun, 
30(7), 807-822. 
Gunderson, B.W., Ross, G.H., Ibrahim, K.H. & Rotschafer, J.C. (2001). What Do We Really 
Know About Antibiotic Pharmacodynamics? Pharmacotherapy, 21(10 Pt 2), 302S-318S. 
Gyrd-Hansen, N., Rasmussen, F. & Smith, M. (1981). Cardiovascular effects of intravenous 
administration of tetracycline in cattle. J Vet Pharmacol Ther, 4(1), 15-25. 
Gyssens, I.C. (1999). Preventing postoperative infections: Current treatment recommendations. 
Drugs, 57(2), 175-185. 
Haven, M.L., Wichtel, J.J., Bristol, D.G., Fetrow, J.F. & Spears, J.W. (1992). Effects of 
antibiotic prophylaxis on postoperative complications after rumenotomy in cattle. J Am 
Vet Med Assoc., 200(9), 1332-1335. 
Howe, L.M. & Boothe, H.W., Jr. (2006). Antimicrobial use in the surgical patient. Vet Clin 
North Am Small Anim Pract, 36(5), 1049-1060, vi. 
JAVMA (2004). Medicated milk replacers can cause illegal residues in veal calves. In 
Medicated milk replacers can cause illegal residues in veal calves. American Veterinary 
Medical Association. 
Jelinski, M. (2006). Personal communication. In Personal communication. 
Jones, G. (1999). On-farm Tests for Drug Residues in Milk. In On-farm Tests for Drug Residues 
in Milk. Virginia Cooperative Extension. 
Kaneene, J.B. & Ahl, A.S. (1987). Drug residues in dairy cattle industry: epidemiological 
evaluation of factors influencing their occurrence. J Dairy Sci, 70(10), 2176-2180. 
Kang, J.H., Jin, J.H. & Kondo, F. (2005). False-positive outcome and drug residue in milk 
samples over withdrawal times. J Dairy Sci, 88(3), 908-913. 
Kanny, G., Puygrenier, J., Beaudoin, E. & Moneret-Vautrin, D.A. (1994). [Alimentary 
anaphylactic shock: implication of penicillin residues]. Allerg Immunol (Paris), 26(5), 
181-183. 
Kersey, R.C., McMahan, J.R., Ottke, R.C. & Sacchi, E.M. (1955). Antibiotic preservation of 
meats. II. Intraperitoneal injection of oxytetracycline in beef cattle. Antibiot Annu, 3, 731-
733. 
Klein, W.R. & Firth, E.C. (1988). Infection rates in clean surgical procedures with and without 
prophylactic antibiotics. Vet Rec, 123(21), 542-543. 
Klein, W.R. & Firth, E.C. (1988). Infection rates in contaminated surgical procedures: a 
comparison of prophylactic treatment for one day or four days. Vet Rec, 123(22), 564-
566. 
Klein, W.R., Firth, E.C., Kievits, J.M.C.A. & De Jager, J.C. (1989). Intra-abdominal versus 
intramuscular application of two ampicillin preparations in cows. J. vet. Pharmacol. 
Therap., 12, 141-146. 
Klein, W.R., van der Velden, M.A. & Ensink, J.M. (1994). Single intraoperative administraion of 
antibiotic to cows with caecal torsion: wound infection and post-operative performance. 
A retrospective and prospective study. Veterinary Quarterly, 16(Supp. 2), S111-113. 
Lindemayr, H., Knobler, R., Kraft, D. & Baumgartner, W. (1981). Challenge of penicillin-
allergic volunteers with penicillin-contaminated meat. Allergy, 36(7), 471-478. 
Lopez-Gatius, F. (2000). Site of semen deposition in cattle: a review. Theriogenology, 53(7), 
1407-1414. 
96 
 
McKellar, Q.A., Sanchez Bruni, S.F. & Jones, D.G. (2004). Pharmacokinetic/pharmacodynamic 
relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary 
Pharmacology and Therapeutics, 27, 503-514. 
Molina, A., Molina, M.P., Althaus, R.L. & Gallego, L. (2003). Residue persistence in sheep milk 
following antibiotic therapy. Vet J, 165(1), 84-89. 
NCIMS (2003). National Milk Drug Residue Data Base Fiscal Year 2003 Annual Report. In 
National Milk Drug Residue Data Base Fiscal Year 2003 Annual Report. 
http://www.cfsan.fda.gov/~ear/milkrp03.html. 
NCIMS (2004). National Milk Drug Residue Data Base Fiscal Year 2003 Annual Report. In 
National Milk Drug Residue Data Base Fiscal Year 2003 Annual Report. 
http://www.cfsan.fda.gov/~ear/milkrp03.html. 
Nicholson, M., Beal, M., Shofer, F. & Brown, D.C. (2002). Epidemiologic evaluation of 
postoperative wound infection in clean-contaminated wounds: A retrospective study of 
239 dogs and cats. Vet Surg, 31(6), 577-581. 
Okuda, T., Katoh, T., Takaichi, K., Matsunaga, H., Uchida, S., Kurokawa, K. & Nihei, H. 
(1986). Pharmacokinetics of cefoperazone in end-stage renal failure patients on 
peritoneal dialysis. Jpn J. Antibiot., 39(10), 2775-2779. 
Paige, J.C., Chaudry, M.H. & Pell, F.M. (1999). Federal surveillance of veterinary drugs and 
chemical residues (with recent data). Vet Clin North Am Food Anim Pract, 15(1), 45-61, 
viii. 
Papich, M.G., Korsrud, G.O., Boison, J.O., Yates, W.D., MacNeil, J.D., Janzen, E.D., Cohen, 
R.D. & Landry, D.A. (1993). A study of the disposition of procaine penicillin G in 
feedlot steers following intramuscular and subcutaneous injection. J Vet Pharmacol Ther, 
16(3), 317-327. 
Papich, M.G., Korsrud, G.O., Boison, J.O., Yates, W.D., MacNeil, J.D., Janzen, E.D., 
McKinnon, J.J. & Landry, D.A. (1994). Disposition of penicillin G after administration 
of benzathine penicillin G, or a combination of benzathine penicillin G and procaine 
penicillin G in cattle. Am J Vet Res, 55(6), 825-830. 
Payne, M.A., Craigmill, A., Riviere, J.E. & Webb, A.I. (2006). Extralabel use of penicillin in 
food animals. J Am Vet Med Assoc, 229(9), 1401-1403. 
Ruegg, P.L. & Tabone, T.J. (2000). The relationship between antibiotic residue violations and 
somatic cell counts in Wisconsin dairy herds. J Dairy Sci, 83(12), 2805-2809. 
Saha, S.K. (1985). Peritoneal lavage with metronidazole. Surg Gynecol Obstet., 160(4), 335-338. 
Salvati, E.P., Rubin, R.J., Eisenstat, T.E. & Bohman, H. (1988). Value of subcutaneous and 
intraperitoneal antibiotics in reducing infection in clean contaminated operations of the 
colon. Surg Gynecol Obstet, 167(4), 315-318. 
Sargeant, J.M., Schukken, Y.H. & Leslie, K.E. (1998). Ontario bulk milk somatic cell count 
reduction program: progress and outlook. J Dairy Sci, 81(6), 1545-1554. 
Saville, W.J., Wittum, T.E. & Smith, K.L. (2000). Association between measures of milk quality 
and risk of violative antimicrobial residues in grade-A raw milk. J Am Vet Med Assoc, 
217(4), 541-545. 
Schneider, A., Sack, U., Rothe, K. & Bennek, J. (2005). Peritoneal taurolidine lavage in children 
with localised peritonitis due to appendicitis. Pediatr Surg Int, 21(6), 445-448. 
Schwartz, M.T., Kowalsky, S.F., McCormick, E.M., Parker, M.A. & Echols, R.M. (1986). 
Clindamycin phosphate kinetics in subjects undergoing CAPD. Clin Nephrol., 26(6), 
303-306. 
97 
 
Seger, T., Grunert, E. & Ahlers, D. (1994). [The cause of complications of abdominal incision 
healing after cesarean section in cattle]. Dtsch Tierarztl Wochenschr, 101(8), 309-311. 
Sinswat, P., Wu, W.J., Sha, S.H. & Schacht, J. (2000). Protection from ototoxicity of 
intraperitoneal gentamicin in guinea pig. Kidney Int, 58(6), 2525-2532. 
Sisterhen, L.L., Stowe, C.D., Farrar, H.C., Blaszak, C.K. & Blaszak, R.T. (2006). Disposition of 
ceftazidime after intraperitoneal administration in adolescent patients receiving 
continuous cycling peritoneal dialysis. Am J Kidney Dis., 47(3), 503-508. 
Stephen, M. & Loewenthal, J. (1979). Continuing peritoneal lavage in high-risk peritonitis. 
Surgery, 85(6), 603-606. 
Sundlof, S.F. (1989). Drug and chemical residues in livestock. Vet Clin North Am Food Anim 
Pract, 5(2), 411-449. 
Tollefson, L. (2004). Developing new regulatory approaches to antimicrobial safety. J Vet Med B 
Infect Dis Vet Public Health, 51(8-9), 415-418. 
Tollefson, L., Morris, D., Boland, C., Kaartinen, L. (2006). Regulation of Antibiotic Use in 
Animals. In Regulation of Antibiotic Use in Animals Ed Giguere, S., Prescott, J.F., 
Baggot, J.D., Walker, R.D., Dowling, P.M. pp. 417-436. Blackwell Publishing, Ames, 
IA. 
Toutain, P.L. & Lees, P. (2004). Integration and modelling of pharmacokinetic and 
pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of 
Veterinary Pharmacology and Therapeutics, 27, 467-477. 
Tyler, J.W., Ruffin, D.C. & Yu, A. (1998). Probable ceftiofur-induced cutaneous drug reaction in 
a cow. Can Vet J, 39(5), 296-298. 
USP (2003). USP Veterinary Pharmaceutical Information Monographs - Antibiotics. J Vet 
Pharmacol Ther, 26(Supplement 2). 
van Schaik, G., Lotem, M. & Schukken, Y.H. (2002). Trends in somatic cell counts, bacterial 
counts, and antibiotic residue violations in New York State during 1999-2000. J Dairy 
Sci, 85(4), 782-789. 
Vasseur, P.B., Paul, H.A., Enos, L.R. & Hirsh, D.C. (1985). Infection rates in clean surgical 
procedures: a comparison of ampicillin prophylaxis vs a placebo. J Am Vet Med Assoc, 
187(8), 825-827. 
VDD (2003). Maximum Residue Limits (MRLs) Frequently Asked Questions. In Maximum 
Residue Limits (MRLs) Frequently Asked Questions. Health Canada. 
VDD (2005). Health Canada's Veterinary Drugs Directorate's (VDD's) Study To Assess Drug 
Use in Animals in Canada. In Health Canada's Veterinary Drugs Directorate's (VDD's) 
Study To Assess Drug Use in Animals in Canada. Health Canada. 
Wallet, F., Toure, F., Devalckenaere, A., Pagniez, D. & Courcol, R.J. (2000). Molecular 
identification of Pasteurella dagmatis peritonitis in a patient undergoing peritoneal 
dialysis. J Clin Microbiol, 38(12), 4681-4682. 
WCABP (2005). Guidelines for Extra Label Drug Use for Bovine Practitioners. In Guidelines 
for Extra Label Drug Use for Bovine Practitioners. 
Weese, J.S. & Halling, K.B. (2006). Perioperative administration of antimicrobials associated 
with elective surgery for cranial cruciate ligament rupture in dogs: 83 cases (2003-2005). 
J Am Vet Med Assoc, 229(1), 92-95. 
Whittem, T. (1999). Pharmacokinetics and milk discard times of pirlimycin after intramammary 
infusion: a population approach. J Vet Pharmacol Ther, 22(1), 41-51. 
98 
 
99 
 
Whittem, T.L., Johnson, A.L., Smith, C.W., Schaeffer, D.J., Coolman, B.R., Averill, S.M., 
Cooper, T.K. & Merkin, G.R. (1999). Effect of perioperative prophylactic antimicrobial 
treatment in dogs undergoing elective orthopedic surgery. J Am Vet Med Assoc, 215(2), 
212-216. 
Wicher, K., Reisman, R. & Arbesman, C. (1969). Allergic reaction to penicillin in milk. Journal 
of the American Medical Association, 208, 143-145. 
Wieriks, J. & Schornagel, H.E. (1971). Animal reactions to, and tolerance of, two local 
anesthetic-free tetracycline preparations injected by various routes. A comparison of 
vendarcin with rolitetracycline. Chemotherapy, 16(2), 85-108. 
Withrow, S.J. & Black, A.P. (1979). Generalized peritonitis in small animals. Vet Clin North Am 
Small Anim Pract, 9(2), 363-379. 
Yelon, J.A., Green, J.D. & Evans, J.T. (1996). Efficacy of an intraperitoneal antibiotic to reduce 
the incidence of infection in the trauma patient: a prospective, randomized study. J Am 
Coll Surg, 182(6), 509-514. 
Zelenitsky, S.A., Ariano, R.E., Harding, G.K.M. & Silverman, R.E. (2002). Antibiotic 
pharmacodynamics in surgical prophylaxis: an association between intraoperative 
antibiotic concentrations and efficacy. Antimicrob. Agents Chemother., 46(9), 3026-3030. 
Zeng, S.S., Hart, S., Escobar, E.N. & Tesfai, K. (1998). Validation of antibiotic residue tests for 
dairy goats. J Food Prot, 61(3), 344-349. 
 
 
 
